<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Cell Mol Med</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Cell. Mol. Med</journal-id>
<journal-id journal-id-type="doi">10.1111/(ISSN)1582-4934</journal-id>
<journal-id journal-id-type="publisher-id">JCMM</journal-id>
<journal-title-group>
<journal-title>Journal of Cellular and Molecular Medicine</journal-title>
</journal-title-group>
<issn pub-type="ppub">1582-1838</issn>
<issn pub-type="epub">1582-4934</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32031298</article-id>
<article-id pub-id-type="pmc">7077554</article-id>
<article-id pub-id-type="doi">10.1111/jcmm.15028</article-id>
<article-id pub-id-type="publisher-id">JCMM15028</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Review</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Reviews</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Therapeutic potential of PPARγ natural agonists in liver diseases</article-title>
<alt-title alt-title-type="left-running-head">WU et al.</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="jcmm15028-cr-0001">
<name>
<surname>Wu</surname>
<given-names>Liwei</given-names>
</name>
<xref ref-type="aff" rid="jcmm15028-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="jcmm15028-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="jcmm15028-cr-0002">
<name>
<surname>Guo</surname>
<given-names>Chuanyong</given-names>
</name>
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0002-6527-4673</contrib-id>
<xref ref-type="aff" rid="jcmm15028-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="jcmm15028-aff-0002">
<sup>2</sup>
</xref>
<address>
<email>guochuanyong@hotmail.com</email>
</address>
</contrib>
<contrib contrib-type="author" corresp="yes" id="jcmm15028-cr-0003">
<name>
<surname>Wu</surname>
<given-names>Jianye</given-names>
</name>
<xref ref-type="aff" rid="jcmm15028-aff-0001">
<sup>1</sup>
</xref>
<address>
<email>wjymail@163.com</email>
</address>
</contrib>
</contrib-group>
<aff id="jcmm15028-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Department of Gastroenterology</named-content>
<named-content content-type="organisation-division">Putuo People’s Hospital</named-content>
<institution>Tongji University School of Medicine</institution>
<city>Shanghai</city>
<country country="CN">China</country>
</aff>
<aff id="jcmm15028-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Department of Gastroenterology</named-content>
<named-content content-type="organisation-division">Shanghai Tenth People’s Hospital</named-content>
<institution>Tongji University School of Medicine</institution>
<city>Shanghai</city>
<country country="CN">China</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break></break>
Chuanyong Guo and Jianye Wu, Department of Gastroenterology, Putuo People’s Hospital, Tongji University School of Medicine, Shanghai 200072, China.<break></break>
Emails: <email>guochuanyong@hotmail.com</email> (CG); <email>wjymail@163.com</email> (JW)<break></break></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>07</day>
<month>2</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="ppub">
<month>3</month>
<year>2020</year>
</pub-date>
<volume>24</volume>
<issue>5</issue>
<issue-id pub-id-type="doi">10.1111/jcmm.v24.5</issue-id>
<fpage>2736</fpage>
<lpage>2748</lpage>
<history>
<date date-type="received">
<day>04</day>
<month>8</month>
<year>2019</year>
</date>
<date date-type="rev-recd">
<day>17</day>
<month>11</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>13</day>
<month>1</month>
<year>2020</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> Copyright &#x000a9; 2020 Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2020 The Authors. <italic>Journal of Cellular and Molecular Medicine</italic> published by Foundation for Cellular and Molecular Medicine and John Wiley &amp; Sons Ltd.</copyright-statement>
<license license-type="creativeCommonsBy">
<license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="file:JCMM-24-2736.pdf"></self-uri>
<abstract id="jcmm15028-abs-0001">
<title>Abstract</title>
<p>Peroxisome proliferator‐activated receptor gamma (PPARγ) is a vital subtype of the PPAR family. The biological functions are complex and diverse. PPARγ plays a significant role in protecting the liver from inflammation, oxidation, fibrosis, fatty liver and tumours. Natural products are a promising pool for drug discovery, and enormous research effort has been invested in exploring the PPARγ‐activating potential of natural products. In this manuscript, we will review the research progress of PPARγ agonists from natural products in recent years and probe into the application potential and prospects of PPARγ natural agonists in the therapy of various liver diseases, including inflammation, hepatic fibrosis, non‐alcoholic fatty liver and liver cancer.</p>
</abstract>
<kwd-group>
<kwd id="jcmm15028-kwd-0001">liver diseases</kwd>
<kwd id="jcmm15028-kwd-0002">natural agonists</kwd>
<kwd id="jcmm15028-kwd-0003">PPARγ</kwd>
</kwd-group>
<funding-group>
<award-group id="funding-0001">
<funding-source>National Natural Science Foundation of Shanghai</funding-source>
<award-id>19ZR1447700</award-id>
</award-group>
<award-group id="funding-0002">
<funding-source>
<institution-wrap>
<institution>National Natural Science Foundation of China </institution>
<institution-id institution-id-type="open-funder-registry">10.13039/501100001809</institution-id>
</institution-wrap>
</funding-source>
<award-id>81670472</award-id>
<award-id>81700502</award-id>
<award-id>81800538</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="4"></fig-count>
<table-count count="3"></table-count>
<page-count count="13"></page-count>
<word-count count="10600"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>March 2020</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.7.8 mode:remove_FC converted:17.03.2020</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<p content-type="self-citation">
<mixed-citation id="jcmm15028-cit-1001" publication-type="journal">
<string-name>
<surname>Wu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Guo</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>J</given-names>
</string-name>. <article-title>Therapeutic potential of PPARγ natural agonists in liver diseases</article-title>. <source xml:lang="en"/>J Cell Mol Med. <year>2020</year>;<volume>24</volume>:<fpage>2736</fpage>–<lpage>2748</lpage>. <pub-id pub-id-type="doi">10.1111/jcmm.15028</pub-id>
</mixed-citation>
</p>
<fn-group id="jcmm15028-ntgp-0001">
<fn fn-type="funding" id="jcmm15028-note-0001">
<p>
<bold>Funding information</bold>
</p>
<p>This work was supported by the National Natural Science Foundation of China (grant numbers 81670472, 81700502 and 81800538) and National Natural Science Foundation of Shanghai (grant number 19ZR1447700).</p>
</fn>
</fn-group>
</notes>
</front>
<body id="jcmm15028-body-0001">
<sec id="jcmm15028-sec-0001">
<label>1</label>
<title>MOLECULAR STRUCTURE OF PEROXISOME PROLIFERATOR‐ACTIVATED RECEPTOR GAMMA (PPARγ)</title>
<p>The PPARs belongs to the superfamily of nuclear hormone receptors and is named for its activation, which is regulated by the peroxisome proliferators. There are three subtypes of PPARs (PPARα, PPARβ and PPARγ). These three subtypes of PPARs are expressed differently in different tissues. PPARα is mainly manifested in cardiomyocytes, hepatocytes, intestinal epithelial cells and renal tubule epithelial cells; PPARβ is found in many tissues, with the higher expression in the intestine, kidney and heart; and PPARγ is mainly expressed in adipose tissue.<xref ref-type="ref" rid="jcmm15028-bib-0001">1</xref>
</p>
<p>PPARs always consist of four domains (A/B, C, D and E/F, Figure <xref ref-type="fig" rid="jcmm15028-fig-0001">1</xref>)The A/B region, located at the N end of the receptor protein, is the active functional region and differs among the subtypes and is independent of ligands. Region C is the DNA binding domain containing two zinc finger structures. Area D is the hinge domain. Region E/F, located at the end of C, is the ligand binding domain and contains a ligand‐dependent transcriptional activation functional region.<xref ref-type="ref" rid="jcmm15028-bib-0002">2</xref> The PPARγ gene can be transcribed into different PPARγ mRNAs and translated into two isoforms [PPAR γ1 and PPAR γ2].<xref ref-type="ref" rid="jcmm15028-bib-0003">3</xref>
</p>
<fig fig-type="Figure" id="jcmm15028-fig-0001" orientation="portrait" position="float" xml:lang="en">
<label>Figure 1</label>
<caption>
<p>PPARγ structure. The A/B region, located at the N end of the receptor protein, is the active functional region. Region C is the DNA binding domain. Area D is the hinge domain. Region E/F, located at the end of C, is the ligand binding domain and contains a ligand‐dependent transcriptional activation functional region</p>
</caption>
<graphic id="nlm-graphic-1" xlink:href="JCMM-24-2736-g001"></graphic>
</fig>
<p>After binding to ligands, PPARγ is activated and combines with retinoids X receptor (RXR) to form a heterodimer. Then, a series of synergistic factors are recruited and combined with the heterodimer to take part in regulating transduction. Typical endogenous ligands for PPARγ include prostaglandins, eicosanoids and fatty acids. At the same time, PPARγ can also directly activate specific genes or conduct gene transduction through DNA‐independent patterns (Figure <xref ref-type="fig" rid="jcmm15028-fig-0002">2</xref>).</p>
<fig fig-type="Figure" id="jcmm15028-fig-0002" orientation="portrait" position="float" xml:lang="en">
<label>Figure 2</label>
<caption>
<p>PPARγ activation. In normal cells, the PPARγ is located in the cytoplasm. After combining with its agonists and retinoid X receptor (RXR), the PPARγ complex translocates to the nucleus where it recognizes specific DNA sequence elements (peroxisome proliferator response element, PPRE) in promoters of target genes</p>
</caption>
<graphic id="nlm-graphic-3" xlink:href="JCMM-24-2736-g002"></graphic>
</fig>
</sec>
<sec id="jcmm15028-sec-0002">
<label>2</label>
<title>FUNCTION AND CELLULAR ROLES OF PPARγ</title>
<p>The biological functions of PPARγ are complex and diverse, including regulation of lipid and carbohydrate metabolism, energy balance, inhibiting inflammation, inducing tumour cell differentiation and apoptosis, inhibiting tumour angiogenesis, anti‐fibrosis and anti‐atherosclerosis, reducing blood fat and blood pressure, improving heart failure and participating in ventricular remodelling. Thus, PPARγ is a current focus of research present. And indeed, there are a number of researchers, who have written review articles to shed more light on the power of PPARγ.</p>
<p>Semple reviewed the function of PPARγ and its variants in metabolic syndrome.<xref ref-type="ref" rid="jcmm15028-bib-0001">1</xref> In addition, Jia,<xref ref-type="ref" rid="jcmm15028-bib-0004">4</xref> Chigurupati<xref ref-type="ref" rid="jcmm15028-bib-0005">5</xref> and Vallée<xref ref-type="ref" rid="jcmm15028-bib-0006">6</xref> analysed therapeutic potential of PPARγ agonists in diabetes. PPARγ agonists improve insulin sensitivity and treat complications of diabetes. PPARγ can stimulate the differentiation of pre‐adipocytes into mature adipocytes and is closely related to adipogenesis in mature adipocytes.<xref ref-type="ref" rid="jcmm15028-bib-0007">7</xref> The beneficial role of PPARγ in regulation immunity was summarized by Samuel Philip Nobs,<xref ref-type="ref" rid="jcmm15028-bib-0008">8</xref> Chung,<xref ref-type="ref" rid="jcmm15028-bib-0009">9</xref> Abdelrahman,<xref ref-type="ref" rid="jcmm15028-bib-0010">10</xref> Giaginis<xref ref-type="ref" rid="jcmm15028-bib-0011">11</xref> and Staels.<xref ref-type="ref" rid="jcmm15028-bib-0012">12</xref> PPARγ inhibits pro‐inflammatory responses by macrophages, DCs, and T cells. Reka,<xref ref-type="ref" rid="jcmm15028-bib-0013">13</xref> Lecarpentier<xref ref-type="ref" rid="jcmm15028-bib-0014">14</xref> and Heudobler<xref ref-type="ref" rid="jcmm15028-bib-0015">15</xref> reviewed the implications for PPARγ in cancer therapy and prevention. Activation of PPARγ by agonists has the ability to inhibit cell proliferation and growth based on the ability to induce differentiation. A number of in vitro and in vivo experiments have shown that PPARγ is expressed in tumour cells and can inhibit the growth of cancer cells after activation, such as breast cancer,<xref ref-type="ref" rid="jcmm15028-bib-0016">16</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0017">17</xref> pancreatic cancer,<xref ref-type="ref" rid="jcmm15028-bib-0018">18</xref> colon cancer<xref ref-type="ref" rid="jcmm15028-bib-0019">19</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0020">20</xref> and gastric cancer.<xref ref-type="ref" rid="jcmm15028-bib-0021">21</xref> Additional results confirmed that decreased expression of PPARγ was found in activated hepatic stellate cells (HSCs), suggesting that the increased expression and activity of PPARγ promoted the recovery of activated HSCs to a resting state.<xref ref-type="ref" rid="jcmm15028-bib-0022">22</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0023">23</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0024">24</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0025">25</xref> Among the multiple biological responses involved, PPARγ plays a corresponding role by regulating the expression of signalling pathways, including JAK‐STAT, NF‐kB, nuclear factor of activated T cell, AP‐1, PI3K, leptin and adiponectin. Therefore, PPARγ is of vital importance when making a diagnosis and selecting treatment for related diseases.</p>
</sec>
<sec id="jcmm15028-sec-0003">
<label>3</label>
<title>PPARγ AGONISTS FROM NATURAL PRODUCTS</title>
<p>Because of the significant role of PPARγ in diseases, the identification of PPARγ agonists is regarded as targets of numerous drug development works. Large amounts of fatty acids and fatty acid derivatives can activate PPARγ. Among the PPARγ activators, long‐chain polyunsaturated fatty acids always show better effects, such as eicosanoids [8‐S‐hydroxyeicosatetraenoic acid and leukotriene B4]. Also, PPARγ can be activated by several prostanoids, such as 15‐deoxy‐Δ12, 14‐prostaglandin J2 (15d‐PGJ2) and 15‐hydroxyeicosatetraenoic acid. The effect of 15d‐PGJ2 has been widely recognized.<xref ref-type="ref" rid="jcmm15028-bib-0011">11</xref> Thiazolidinediones (TZDs) are synthetic ligands of PPARγ and are well‐known for excellent potency in regulating blood glucose levels and insulin sensitivity.<xref ref-type="ref" rid="jcmm15028-bib-0026">26</xref> However, the undesirable side effects, such as fluid retention, weight gain, cardiac hypertrophy and hepatotoxicity, have limited the clinical use of TZDs.<xref ref-type="ref" rid="jcmm15028-bib-0005">5</xref> Thus, searching for drugs with a similar clinical function, but fewer side effects has become a new direction of effort. Natural products are rich sources of drug discovery; thus, natural products are a focus of research.<xref ref-type="ref" rid="jcmm15028-bib-0027">27</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0028">28</xref>
</p>
<p>Previous studies have successfully demonstrated various PPARγ agonists from natural resources by using reporter gene assays, pharmacophore models, silicon screening and virtual screening approaches. A cell‐based luciferase reporter system may become a suitable method to detect bioavailability of nuclear receptors, including PPARs.<xref ref-type="ref" rid="jcmm15028-bib-0029">29</xref> Rasmus<xref ref-type="ref" rid="jcmm15028-bib-0030">30</xref> demonstrated that the pharmacophore model can be used to select novel PPARs agonists. In addition, Jang and Peng<xref ref-type="ref" rid="jcmm15028-bib-0031">31</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0032">32</xref> identified promising PPARγ agonists on the basis of structure analyses. Since the first time that virtual screening (VS) was used to identify novel PPARγ agonists by Salam et al,<xref ref-type="ref" rid="jcmm15028-bib-0033">33</xref> more and more researchers have begun using in silico methods alone or combined with other approaches, such as in vivo or in vitro experiments,<xref ref-type="ref" rid="jcmm15028-bib-0034">34</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0035">35</xref> structure analyses<xref ref-type="ref" rid="jcmm15028-bib-0036">36</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0037">37</xref> and some databases,<xref ref-type="ref" rid="jcmm15028-bib-0036">36</xref> to find novel agonists as potential candidates to treat diseases.<xref ref-type="ref" rid="jcmm15028-bib-0038">38</xref> The functionality of some approaches has been verified.</p>
<p>To review PPARγ agonists from natural products we checked the database, DrugBank (<ext-link ext-link-type="uri" xlink:href="http://www.drugbank.ca">http://www.drugbank.ca</ext-link>), which combines bio‐ and chem‐informatics. Table <xref ref-type="table" rid="jcmm15028-tbl-0001">1</xref> shows our results. Resveratrol, curcumin, isoflavone, cannabidiol, nabiximols and medical cannabis have been confirmed to have the agonist role.</p>
<table-wrap id="jcmm15028-tbl-0001" orientation="portrait" position="float" xml:lang="en">
<label>Table 1</label>
<caption>
<p>PPARγ natural agonists in DrugBank</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">DrugBank ID</th>
<th align="left" colspan="1" rowspan="1" valign="top">Name</th>
<th align="left" colspan="1" rowspan="1" valign="top">Structure</th>
<th align="left" colspan="1" rowspan="1" valign="top">Function description</th>
<th align="left" colspan="1" rowspan="1" valign="top">References</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">DB02709</td>
<td align="left" colspan="1" rowspan="1">Resveratrol</td>
<td align="left" colspan="1" rowspan="1">
<inline-graphic xlink:href="JCMM-24-2736-g005.jpg" xlink:title="image"></inline-graphic>
</td>
<td align="left" colspan="1" rowspan="1">Antioxidant, anti‐inflammatory, anti‐cancer</td>
<td align="left" colspan="1" rowspan="1">
<xref ref-type="ref" rid="jcmm15028-bib-0042">42</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0095">95</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0112">112</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0113">113</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0114">114</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0115">115</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">DB11672,14635</td>
<td align="left" colspan="1" rowspan="1">Curcumin, Curcumin sulphate</td>
<td align="left" colspan="1" rowspan="1">
<inline-graphic xlink:href="JCMM-24-2736-g006.jpg" xlink:title="image"></inline-graphic>
</td>
<td align="left" colspan="1" rowspan="1">Anti‐inflammatory, antioxidant, metabolic regulation</td>
<td align="left" colspan="1" rowspan="1">
<xref ref-type="ref" rid="jcmm15028-bib-0068">68</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0072">72</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0073">73</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0116">116</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0117">117</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0118">118</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0119">119</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0120">120</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">DB12007</td>
<td align="left" colspan="1" rowspan="1">Isoflavone</td>
<td align="left" colspan="1" rowspan="1">
<inline-graphic xlink:href="JCMM-24-2736-g007.jpg" xlink:title="image"></inline-graphic>
</td>
<td align="left" colspan="1" rowspan="1">Anti‐inflammatory, antioxidant, anti‐cancer</td>
<td align="left" colspan="1" rowspan="1">
<xref ref-type="ref" rid="jcmm15028-bib-0108">108</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0121">121</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0122">122</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">DB14009(09061,14011)</td>
<td align="left" colspan="1" rowspan="1">Medical Cannabis (Cannabidiol, Nabiximols)</td>
<td align="left" colspan="1" rowspan="1">
<inline-graphic xlink:href="JCMM-24-2736-g008.jpg" xlink:title="image"></inline-graphic>
</td>
<td align="left" colspan="1" rowspan="1">Antioxidant, anti‐inflammatory, neuroprotective</td>
<td align="left" colspan="1" rowspan="1">
<xref ref-type="ref" rid="jcmm15028-bib-0122">122</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0123">123</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0124">124</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0125">125</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0126">126</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0127">127</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0128">128</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0129">129</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0130">130</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0131">131</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0132">132</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0133">133</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0134">134</xref>
</td>
</tr>
</tbody>
</table>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
<p>Not surprisingly, an abundance of research efforts has been undertaken to explore the potential applications of full or partial PPARγ natural agonists. Table <xref ref-type="table" rid="jcmm15028-tbl-0002">2</xref> exhibits the natural agonists and their functions, which have been discussed in recent years. After reviewing the reported agonists, we found that the majority are flavonoids or isoflavonoids. Most of the other agonists are stilbenes, polyacetylenes, amorfrutins, sesquiterpene lactones and derivatives of diterpenequinone. The diversity of agonists depends on the large size of the LBD binding pocket and its flexibility.</p>
<table-wrap id="jcmm15028-tbl-0002" orientation="portrait" position="float" xml:lang="en">
<label>Table 2</label>
<caption>
<p>Discussed natural agonists of PPARγ (from 2010 to 2019)</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">Functions</th>
<th align="left" colspan="1" rowspan="1" valign="top">Agonists</th>
<th align="left" colspan="1" rowspan="1" valign="top">Years</th>
<th align="left" colspan="1" rowspan="1" valign="top">References</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="3">Anti‐cancer</td>
<td align="left" colspan="1" rowspan="1">
<italic>Chromolaena odorata</italic>, Luteolin, Stereoisomers ginsenosides</td>
<td align="left" colspan="1" rowspan="1">2012</td>
<td align="left" colspan="1" rowspan="1">
<xref ref-type="ref" rid="jcmm15028-bib-0136">136</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0137">137</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0138">138</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0139">139</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0140">140</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>Turbinaria ornata</italic> and <italic>Padina pavonica</italic>
</td>
<td align="left" colspan="1" rowspan="1">2015</td>
<td align="left" colspan="1" rowspan="1">
<xref ref-type="ref" rid="jcmm15028-bib-0141">141</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Resveratrol</td>
<td align="left" colspan="1" rowspan="1">2016, 2019</td>
<td align="left" colspan="1" rowspan="1">
<xref ref-type="ref" rid="jcmm15028-bib-0042">42</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0095">95</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0113">113</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0115">115</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="3">Anti‐fibrosis</td>
<td align="left" colspan="1" rowspan="1">Puerarin</td>
<td align="left" colspan="1" rowspan="1">2013, 2017</td>
<td align="left" colspan="1" rowspan="1">
<xref ref-type="ref" rid="jcmm15028-bib-0074">74</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Piperine</td>
<td align="left" colspan="1" rowspan="1">2017</td>
<td align="left" colspan="1" rowspan="1">
<xref ref-type="ref" rid="jcmm15028-bib-0143">143</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Berberine</td>
<td align="left" colspan="1" rowspan="1">2018</td>
<td align="left" colspan="1" rowspan="1">
<xref ref-type="ref" rid="jcmm15028-bib-0144">144</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="8">Anti‐inflammation</td>
<td align="left" colspan="1" rowspan="1">Monascin</td>
<td align="left" colspan="1" rowspan="1">2011, 2014</td>
<td align="left" colspan="1" rowspan="1">
<xref ref-type="ref" rid="jcmm15028-bib-0145">145</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0146">146</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0147">147</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Astaxanthin, Ankaflavin, Biochanin A, Cullin‐3, Danhong, Daidzein</td>
<td align="left" colspan="1" rowspan="1">2012</td>
<td align="left" colspan="1" rowspan="1">
<xref ref-type="ref" rid="jcmm15028-bib-0148">148</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0149">149</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0150">150</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0151">151</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0152">152</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0153">153</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Ursolic acid, Epigallocatechin gallate, Monascin</td>
<td align="left" colspan="1" rowspan="1">2013</td>
<td align="left" colspan="1" rowspan="1">
<xref ref-type="ref" rid="jcmm15028-bib-0154">154</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0155">155</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0156">156</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Rhizoma Dioscoreae Nipponicae polysaccharides, Harpagoside, Tectorigenin, Chrysin</td>
<td align="left" colspan="1" rowspan="1">2015</td>
<td align="left" colspan="1" rowspan="1">
<xref ref-type="ref" rid="jcmm15028-bib-0157">157</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0158">158</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0159">159</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0160">160</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Huangkui, Tripchlorolide, <italic>Kochia scoparia</italic> and <italic>Rosa multiflora</italic>, Resveratrol, Chrysin, Daidzein</td>
<td align="left" colspan="1" rowspan="1">2016</td>
<td align="left" colspan="1" rowspan="1">
<xref ref-type="ref" rid="jcmm15028-bib-0115">115</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0121">121</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0161">161</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0162">162</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0163">163</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0164">164</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Astragalus, Fraglide‐1, Madecassic acid, Epigallocatechin Gallate, Hesperetin</td>
<td align="left" colspan="1" rowspan="1">2017</td>
<td align="left" colspan="1" rowspan="1">
<xref ref-type="ref" rid="jcmm15028-bib-0066">66</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Isoprenylated flavonoid, chrysogenum J08NF‐4, <italic>Portulaca oleracea</italic> L., Betulin, <italic>Terminalia arjuna</italic>, Naringin</td>
<td align="left" colspan="1" rowspan="1">2018</td>
<td align="left" colspan="1" rowspan="1">
<xref ref-type="ref" rid="jcmm15028-bib-0069">69</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0169">169</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0170">170</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0171">171</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0172">172</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0173">173</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Beta‐caryophyllene, Wogonin, Resveratrol, Hesperetin</td>
<td align="left" colspan="1" rowspan="1">2019</td>
<td align="left" colspan="1" rowspan="1">
<xref ref-type="ref" rid="jcmm15028-bib-0113">113</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0174">174</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0175">175</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0176">176</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="9">Metabolism regulation</td>
<td align="left" colspan="1" rowspan="1">Cerco‐A, Mycophenolic acid, Fructus Schisandrae, Monascin</td>
<td align="left" colspan="1" rowspan="1">2011</td>
<td align="left" colspan="1" rowspan="1">
<xref ref-type="ref" rid="jcmm15028-bib-0156">156</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0177">177</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0178">178</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0179">179</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Ankaflavin, Astaxanthin, Danhong</td>
<td align="left" colspan="1" rowspan="1">2012</td>
<td align="left" colspan="1" rowspan="1">
<xref ref-type="ref" rid="jcmm15028-bib-0149">149</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0150">150</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0152">152</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Amorfrutin, Honokiol, Monascin</td>
<td align="left" colspan="1" rowspan="1">2013</td>
<td align="left" colspan="1" rowspan="1">
<xref ref-type="ref" rid="jcmm15028-bib-0156">156</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0180">180</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0181">181</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Chebulagic acid, Monascin</td>
<td align="left" colspan="1" rowspan="1">2014</td>
<td align="left" colspan="1" rowspan="1">
<xref ref-type="ref" rid="jcmm15028-bib-0145">145</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0147">147</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0182">182</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Kaempferol, <italic>Lonicera japonica</italic> Thunb, Quercetin, Tectorigenin</td>
<td align="left" colspan="1" rowspan="1">2015</td>
<td align="left" colspan="1" rowspan="1">
<xref ref-type="ref" rid="jcmm15028-bib-0160">160</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0183">183</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0184">184</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Osthole, Isorhamnetin, Huangkui, Saponins and sapogenins, Resveratrol, quercetin</td>
<td align="left" colspan="1" rowspan="1">2016</td>
<td align="left" colspan="1" rowspan="1">
<xref ref-type="ref" rid="jcmm15028-bib-0095">95</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0162">162</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0185">185</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0186">186</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0187">187</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0188">188</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">ZINC13408172, 4292805, 44179 and 901461, Lycium, Astragalus, Tetrahydrocannabinolic acid, Astragaloside IV</td>
<td align="left" colspan="1" rowspan="1">2017</td>
<td align="left" colspan="1" rowspan="1">
<xref ref-type="ref" rid="jcmm15028-bib-0168">168</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0189">189</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0190">190</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0191">191</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0192">192</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Betulin, Chlorogenic acid, Isoprenylated flavonoid, Gentiopicroside, Geranylgeraniol, Moringa concanensis Nimmo, <italic>Terminalia arjuna</italic>, Saponins and sapogenins</td>
<td align="left" colspan="1" rowspan="1">2018</td>
<td align="left" colspan="1" rowspan="1">
<xref ref-type="ref" rid="jcmm15028-bib-0169">169</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0170">170</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0172">172</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0193">193</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0194">194</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0195">195</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0196">196</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>Kaempferia parviflora</italic>, Moringa concanensis Nimmo, Resveratrol</td>
<td align="left" colspan="1" rowspan="1">2019</td>
<td align="left" colspan="1" rowspan="1">
<xref ref-type="ref" rid="jcmm15028-bib-0042">42</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0095">95</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0197">197</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0198">198</xref>
</td>
</tr>
</tbody>
</table>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
<p>Meanwhile, there are new trends in the treatment of liver disease which are using dual PPARα/γ or PPAR δ/γ agonists and pan agonists to enhance treatment efficacy.<xref ref-type="ref" rid="jcmm15028-bib-0039">39</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0040">40</xref> Of note, synthetic dual or pan PPAR agonists were discontinued due to adverse events.<xref ref-type="ref" rid="jcmm15028-bib-0041">41</xref> It has been showed that resveratrol,<xref ref-type="ref" rid="jcmm15028-bib-0042">42</xref> carvacrol,<xref ref-type="ref" rid="jcmm15028-bib-0043">43</xref> osthole,<xref ref-type="ref" rid="jcmm15028-bib-0044">44</xref> dark tea extracts,<xref ref-type="ref" rid="jcmm15028-bib-0045">45</xref> isoprenols,<xref ref-type="ref" rid="jcmm15028-bib-0046">46</xref> pseudolaric acid B,<xref ref-type="ref" rid="jcmm15028-bib-0047">47</xref> mulberry leaf water extract, Korean red ginseng, banaba leaf water extract,<xref ref-type="ref" rid="jcmm15028-bib-0048">48</xref> and cannabinoids<xref ref-type="ref" rid="jcmm15028-bib-0049">49</xref> activate two or three isotypes of PPARs, and can therefore be used for regulate metabolism. And the compound functions are discussed below.</p>
<p>The liver is the centre of bio‐transformation and detoxification of numerous metabolites and toxicants. Exposure to high levels of exogenous or endogenous toxins may lead to liver damage, which ranges from a transient elevation of liver enzymes to hepatic inflammation, fibrosis, cirrhosis and cancer. Although the expression of PPARγ is always at a low level in liver, PPARγ agonists exhibit various PPARγ‐dependent or PPARγ‐independent effects in liver.<xref ref-type="ref" rid="jcmm15028-bib-0050">50</xref> In addition, researches on our team have focused on the prevention and therapy of liver diseases in recent years. We also have published some reports on the effects of PPARs in liver diseases. The protective effects of many Chinese herbal medicines, such as quercetin,<xref ref-type="ref" rid="jcmm15028-bib-0051">51</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0052">52</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0053">53</xref> oleanolic acid,<xref ref-type="ref" rid="jcmm15028-bib-0054">54</xref> proanthocyanidin B2,<xref ref-type="ref" rid="jcmm15028-bib-0055">55</xref> epigallocatechin‐3‐gallate,<xref ref-type="ref" rid="jcmm15028-bib-0056">56</xref> isorhamnetin<xref ref-type="ref" rid="jcmm15028-bib-0057">57</xref> and genistein,<xref ref-type="ref" rid="jcmm15028-bib-0058">58</xref> in liver diseases have been confirmed by our studies.</p>
<p>In fact, some of the Chinese herbal medicines or plants extracts have been reported to have a close relationship with PPARs, and a range of PPARγ activating natural products were recently recognized that possess a great potential to be further explored for the therapeutic effectiveness in liver diseases; but it has not thoroughly reviewed, and its natural agonists have been evaluated even less. Even, few reviews of the effects of PPARγ natural agonists in liver disease have been published. Understanding the role natural products play, as well as their therapeutic potential for fighting liver diseases, including hepatitis, fibrosis, fatty liver and liver cancer, is critical for future progress. Therefore, our present review summarizes the latest research progress of PPARγ agonists from natural products in recent years and explores the application prospect of PPARγ natural agonists in the treatment of liver diseases.</p>
</sec>
<sec id="jcmm15028-sec-0004">
<label>4</label>
<title>PPARγ NATURAL AGONISTS AND LIVER DISEASES</title>
<sec id="jcmm15028-sec-0005">
<label>4.1</label>
<title>PPARγ natural agonists in hepatitis‐associated inflammation</title>
<p>Inflammation is provoked by pathogenic agents, physical or chemical harm, and ischaemic or autoimmune injury, and it is a vital response for protection. The role of PPARγ in the regulation of inflammatory responses has received particular attention. PPARγ appears to be expressed in many cell types of the immune system, such as macrophages, dendritic cells, platelets, T cells and B cells.<xref ref-type="ref" rid="jcmm15028-bib-0059">59</xref> In addition, PPARγ has been shown in numerous studies to affect the expression of pro‐inflammatory, anti‐inflammatory and pro‐resolving cytokines.<xref ref-type="ref" rid="jcmm15028-bib-0060">60</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0061">61</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0062">62</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0063">63</xref> (Figure <xref ref-type="fig" rid="jcmm15028-fig-0003">3</xref>).</p>
<fig fig-type="Figure" id="jcmm15028-fig-0003" orientation="portrait" position="float" xml:lang="en">
<label>Figure 3</label>
<caption>
<p>PPARγ natural agonists and inflammation. PPARγ natural agonists can regulate inflammatory responses. PPARγ natural agonists promote the activation of macrophages, the apoptosis of neutrophils and B cells, and the expression of some anti‐inflammatory cytokines. In addition, PPARγ suppresses the function of T cells and decreases the expression of some pro‐inflammatory cytokines</p>
</caption>
<graphic id="nlm-graphic-5" xlink:href="JCMM-24-2736-g003"></graphic>
</fig>
<p>Feng reported that apigenin activates PPARγ and ameliorates inflammation via regulation of macrophage polarization.<xref ref-type="ref" rid="jcmm15028-bib-0064">64</xref> Apigenin (4,5,7‐trihydroxyflavone) is a plant flavonoid abundant in fruits and vegetables that acts as a PPARγ modulator by binding and activating the PPARγ. Moreover, PPARγ is regarded as a modulator of macrophage polarization. Apigenin activates PPARγ and inhibits p65 translocation into the nucleus, favouring M2 macrophage polarization. The ability of apigenin in reversing M1 macrophages into M2 macrophages was confirmed based on in vivo experiments in mice.<xref ref-type="ref" rid="jcmm15028-bib-0065">65</xref> Apigenin decreased the secretion levels of interleukin(IL)‐1β, IL‐6, IL‐12 and TNF‐α both in vitro and in vivo. Hesperidin is a flavanone glycoside in citrus fruits. When detecting the effect of hesperidin in diethylnitrosamine‐induced hepatocarcinogenesis, Mahmoud found that hesperidin ameliorates oxidative stress and inflammation, dramatically up‐regulates the expression of PPARγ, and significantly prevents liver damage.<xref ref-type="ref" rid="jcmm15028-bib-0066">66</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0067">67</xref> The anti‐inflammatory effect of curcumin, a natural polyphenolic compound, was reported by El‐Naggar et al.<xref ref-type="ref" rid="jcmm15028-bib-0068">68</xref> In streptozotocin‐induced diabetic rats, the up‐regulation of alanine aminotransferase, aspartate aminotransferase, cyclooxygenase, transforming growth factor‐β1 and nuclear factor kappa B were reversed by curcumin via its promotion of PPARγ expression. In an investigation of the jellyfish‐derived fungus, <italic>Penicillium chrysogenum</italic> J08NF‐4, researchers described a new meroterpene derivative, chrysogenester, which has been defined as a PPARγ agonist. In this study, Lius found that chrysogenester activates PPARγ in Ac2F liver cells and increases nuclear PPARγ protein in RAW 264.7 macrophages. Chrysogenester inhibits phosphorylation of the NF‐κB and suppressed the expression of pro‐inflammatory cytokines, including NO, TNF‐α, IL‐1β and IL‐6.<xref ref-type="ref" rid="jcmm15028-bib-0069">69</xref>
</p>
<p>These reports confirmed the function of PPARγ natural agonists in liver inflammation. The anti‐inflammatory properties of betulin, biochanin A, epigallocatechin gallate, harpagoside, madecassic acid, monascin, resveratrol, rhizoma dioscoreae nipponicae polysaccharides and ursolic acid, which can increase the expression of PPARγ, have been explored by many other scientists. These findings provide evidence for the application prospect of PPARγ natural agonists in inflammatory liver diseases.</p>
</sec>
<sec id="jcmm15028-sec-0006">
<label>4.2</label>
<title>PPARγ natural agonists in liver fibrosis</title>
<p>Liver fibrosis is a chronic and dynamic pathophysiological process, and commonly, excessive secretion and deposition of matrix proteins by HSCs is a pivotal step. Liver fibrosis is closely connected with hepatitis virus infection, alcohol and lipids. The expression of PPARγ is high expression in quiescent HSCs; however, PPARγ is suppressed during fibrosis process. Studies have shown that PPARγ activation blocks HSCs activation and reduces collagen deposition during hepatic fibrogenesis. Thus, PPARγ is an effective target in anti‐fibrosis therapy.<xref ref-type="ref" rid="jcmm15028-bib-0070">70</xref> Also, most PPARγ agonists from nature are partial agonists and always play a biological role by regulating the expression of a variety of genes, resulting in achieving better results. Thus, more and more authorities believe PPARγ agonists could become available therapeutic agents (Figure <xref ref-type="fig" rid="jcmm15028-fig-0004">4</xref>).</p>
<fig fig-type="Figure" id="jcmm15028-fig-0004" orientation="portrait" position="float" xml:lang="en">
<label>Figure 4</label>
<caption>
<p>PPARγ natural agonists and liver fibrosis. Activation of HSCs is closely connected with viral infections, injury alcohol, diet and drugs. PPARγ is highly expressed in quiescent HSCs; however, PPARγ is suppressed during the process of fibrosis. PPARγ natural agonists block HSC activation and reduce collagen deposition during hepatic fibrogenesis</p>
</caption>
<graphic id="nlm-graphic-7" xlink:href="JCMM-24-2736-g004"></graphic>
</fig>
<p>Curcumin, for acid polyphenols, is a yellow pigment in turmeric. Zheng and Chen have verified curcumin function inducing PPARγ expression in activated HSCs and suppressing extracellular matrix production (ECM). They found that curcumin could stimulate the trans‐activation activity of PPARγ, and thus reduce HSC proliferation, induce apoptosis, down‐regulate the expression of ECM gene expression and regulate pathways of TGF‐β and connective tissue growth factor.<xref ref-type="ref" rid="jcmm15028-bib-0071">71</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0072">72</xref> Guo et al described the anti‐fibrotic role of puerarin, an active ingredient from kudzu root. Puerarin effectively attenuated liver damage by up‐regulating PPARγ expression in CCl<sub>4</sub>‐induced hepatic fibrosis. Puerarin can reverse the changes in serum hepatic enzyme activity, reduce ECM deposition and regulate the expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinase (TIMPs).<xref ref-type="ref" rid="jcmm15028-bib-0073">73</xref> Monascin is derived from monascus‐fermented secondary metabolites. It has been shown that monascin rescues the inhibited expression of PPARγ. In HSCs from carboxymethyllysine‐induced fibrosis, monascin attenuates α‐smooth muscle actin and reactive oxygen species generation. Monascin may slow or even block the progression of liver fibrosis through activation of PPARγ.<xref ref-type="ref" rid="jcmm15028-bib-0074">74</xref> Chois reported that capsaicininhibits liver fibrosis by restraining the TGF‐β1 pathway expression via activation of PPARγ. This report described the protective effect of capsaicin. The mechanism of action of capsaicin includes the reduction of oxidative stress and inflammatory response, induction of HSCs apoptosis and repression of ECM production.<xref ref-type="ref" rid="jcmm15028-bib-0075">75</xref>
</p>
</sec>
<sec id="jcmm15028-sec-0007">
<label>4.3</label>
<title>PPARγ natural agonists in liver cancer</title>
<p>More than one decade ago, PPARγ was reported to be closely related to the formation of liver tumours in animals. Researchers found that oestrogen can activate PPARγ by inducing the formation of the metabolite of prostaglandin D2, then activated PPARγ can promote the proliferation of peroxidase bodies, finally causing oxidative DNA damage. This process is closely related to the formation of hepatic tumours.<xref ref-type="ref" rid="jcmm15028-bib-0076">76</xref> However, with the deepening of research, people have different definitions about the role of PPARγ in the development of liver cancer.<xref ref-type="ref" rid="jcmm15028-bib-0077">77</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0078">78</xref> Koga<xref ref-type="ref" rid="jcmm15028-bib-0079">79</xref> reported that the expression of PPARγ in liver cancer was very similar to that in surrounding non‐tumorous cirrhotic liver; however, the number of cases was small. Schaefer<xref ref-type="ref" rid="jcmm15028-bib-0080">80</xref> and Lin<xref ref-type="ref" rid="jcmm15028-bib-0081">81</xref> found that PPARγ is highly expressed in hepatic cancer tissues and in HCC cell lines, and the inhibition of PPARγ function could cause HCC cell death. At the same time, other papers analysed the expression of PPARγ in human HCC tissues and adjacent non‐tumorous liver tissue, and found a significant decrease in HCC tissues, thus showing us that PPARγ ligands, including thiazolidinediones. TZDs and 15‐deoxy‐Δ12,14‐prostaglandin J2 inhibit growth and induce apoptosis of liver cancer cells.<xref ref-type="ref" rid="jcmm15028-bib-0082">82</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0083">83</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0084">84</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0085">85</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0086">86</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0087">87</xref>
</p>
<p>When scientists shifted their perspective to natural agonists of PPARγ, the potential in HCC therapy was shown. Avicularin is a bioactive flavonoid from various plants. Researchers use Huh7 cells to investigate the effect of avicularin in HCC. The results indicated that avicularin treatment decreased cell proliferation, inhibited cell migration and invasion in HCC and induced cell apoptosis via inhibiting the G0/G1‐phase cells and decreasing the accumulation of S‐phase cells. Moreover, the demonstrated anti‐cancer efficacy of avicularin was at least partly dependent on its activation of PPARγ activities.<xref ref-type="ref" rid="jcmm15028-bib-0088">88</xref> Another flavonoid, hispidulin, exhibits potent cytotoxicity towards a variety of human cancers. Hans confirmed the protective effect of hispidulin on HCC both in vitro and in vivo. Hispidulin triggered apoptosis, inhibited cell migration and invasion, and activated PPARγ signalling. The animal experiments showed that hispidulin administration could suppress tumour growth and lung metastasis.<xref ref-type="ref" rid="jcmm15028-bib-0089">89</xref> Huangs studied the combined effects of chrysin and apigenin, both of which are found in <italic>Morinda citrifolia</italic>, in liver cancer. These two drugs were used in both in vivo and in vitro experiments, and authors found they could inhibit cancer cell growth, disorganize cell cycle distributions and suppress cancer cell migration. The combined effects were better, compared with either alone.<xref ref-type="ref" rid="jcmm15028-bib-0090">90</xref> Vara team detected the anti‐proliferative effects of cannabinoids in hepatocellular carcinoma on HepG2 and HUH‐7 cell lines in vitro and in vivo. Δ9‐tetrahydrocannabinol and JWH‐015 are two famous cannabinoids, and they could inhibit cancer cell proliferation and induce autophagy. The activity and intracellular level of PPARγ were increased by them, and the effects can be abolished by a PPARγ inhibitor.<xref ref-type="ref" rid="jcmm15028-bib-0091">91</xref>
</p>
<p>The studies on the favourable effects of PPARγ natural agonists for HCC were few, and researches for several other types of cancer are listed in Table <xref ref-type="table" rid="jcmm15028-tbl-0003">3</xref>.<xref ref-type="ref" rid="jcmm15028-bib-0016">16</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0092">92</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0093">93</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0094">94</xref> To some extent, they can also demonstrate the potential of PPARγ natural agonists as anti‐liver cancer agents.</p>
<table-wrap id="jcmm15028-tbl-0003" orientation="portrait" position="float" xml:lang="en">
<label>Table 3</label>
<caption>
<p>Anti‐cancer effect of PPARγ natural agonists</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">Agonists</th>
<th align="left" colspan="1" rowspan="1" valign="top">Cancer type</th>
<th align="left" colspan="1" rowspan="1" valign="top">Function</th>
<th align="left" colspan="1" rowspan="1" valign="top">References</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Cladosporol A</td>
<td align="left" colspan="1" rowspan="1">Colorectal cancer cell</td>
<td align="left" colspan="1" rowspan="1">Inhibit proliferation, up‐regulate 3 p21waf1/cip1 gene expression, inactivate β‐catenin/TCF pathway</td>
<td align="char" char="." colspan="1" rowspan="1">
<xref ref-type="ref" rid="jcmm15028-bib-0094">94</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Morusin</td>
<td align="left" colspan="1" rowspan="1">Breast cancer cell</td>
<td align="left" colspan="1" rowspan="1">Inhibit proliferation, induce adipogenic differentiation, apoptosis and lipoapoptosis of cancer cells, up‐regulate expressions of C/EBPβ</td>
<td align="char" char="." colspan="1" rowspan="1">
<xref ref-type="ref" rid="jcmm15028-bib-0016">16</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Carotenoids</td>
<td align="left" colspan="1" rowspan="1">Leukaemia K562 cells</td>
<td align="left" colspan="1" rowspan="1">Inhibit proliferation, decrease the viability, induced G0/G1 cell cycle arrest, up‐regulate the expression of Nrf2</td>
<td align="char" char="." colspan="1" rowspan="1">
<xref ref-type="ref" rid="jcmm15028-bib-0093">93</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Chrysin</td>
<td align="left" colspan="1" rowspan="1">Breast cancer cell</td>
<td align="left" colspan="1" rowspan="1">Inhibit proliferation, decrease the viability, inhibit epithelial‐mesenchymal transition</td>
<td align="char" char="." colspan="1" rowspan="1">
<xref ref-type="ref" rid="jcmm15028-bib-0091">91</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">6‐Shogaol</td>
<td align="left" colspan="1" rowspan="1">Breast and colon cancer cell</td>
<td align="left" colspan="1" rowspan="1">Inhibit proliferation, induced G2/M cell cycle arrest</td>
<td align="char" char="." colspan="1" rowspan="1">
<xref ref-type="ref" rid="jcmm15028-bib-0019">19</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Bitter gourd seed</td>
<td align="left" colspan="1" rowspan="1">Colon cancer cell</td>
<td align="left" colspan="1" rowspan="1">Inhibit proliferation, induce apoptosis and up‐regulate GADD45, p53</td>
<td align="char" char="." colspan="1" rowspan="1">
<xref ref-type="ref" rid="jcmm15028-bib-0020">20</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Deoxyelephantopin</td>
<td align="left" colspan="1" rowspan="1">Hela cells</td>
<td align="left" colspan="1" rowspan="1">Inhibit proliferation, induce apoptosis and cell cycle arrest at G(2)/M phase</td>
<td align="char" char="." colspan="1" rowspan="1">
<xref ref-type="ref" rid="jcmm15028-bib-0199">199</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Dihydroartemisinin</td>
<td align="left" colspan="1" rowspan="1">Colon cancer cell</td>
<td align="left" colspan="1" rowspan="1">Inhibit proliferation, induce apoptosis</td>
<td align="char" char="." colspan="1" rowspan="1">
<xref ref-type="ref" rid="jcmm15028-bib-0200">200</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">isoprenols</td>
<td align="left" colspan="1" rowspan="1">Colon cancer cell</td>
<td align="left" colspan="1" rowspan="1">Induce apoptosis</td>
<td align="char" char="." colspan="1" rowspan="1">
<xref ref-type="ref" rid="jcmm15028-bib-0201">201</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Hydroxysafflor‐Yellow A</td>
<td align="left" colspan="1" rowspan="1">Gastric carcinoma cell</td>
<td align="left" colspan="1" rowspan="1">Inhibit proliferation, induce apoptosis and cell cycle arrest at G0/G1 phase</td>
<td align="char" char="." colspan="1" rowspan="1">
<xref ref-type="ref" rid="jcmm15028-bib-0202">202</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Luteolin</td>
<td align="left" colspan="1" rowspan="1">Colorectal cancer cell</td>
<td align="left" colspan="1" rowspan="1">Luteolin‐mediated OCTN2 expression and activity potentiate the sensitivity of cancer cells to oxaliplatin</td>
<td align="char" char="." colspan="1" rowspan="1">
<xref ref-type="ref" rid="jcmm15028-bib-0203">203</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Lycopene</td>
<td align="left" colspan="1" rowspan="1">Prostate cancer cell</td>
<td align="left" colspan="1" rowspan="1">Inhibit proliferation</td>
<td align="char" char="." colspan="1" rowspan="1">204</td>
</tr>
</tbody>
</table>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
</sec>
<sec id="jcmm15028-sec-0008">
<label>4.4</label>
<title>PPARγ natural agonists in non‐alcoholic fatty liver disease (NAFLD)</title>
<p>Fatty liver disease, due to input/output imbalance of hepatic free fatty acid(FFA) metabolism, is regarded as one of the most common chronic liver diseases worldwide. Insulin resistance and oxygen stress are regarded as the central to development. The multi‐layer and multi‐angle function of PPARγ have been confirmed by many researchers.<xref ref-type="ref" rid="jcmm15028-bib-0095">95</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0096">96</xref> As we mentioned above, PPARγ activation down‐regulate inflammatory response,<xref ref-type="ref" rid="jcmm15028-bib-0097">97</xref> inhibit HSCs activation,<xref ref-type="ref" rid="jcmm15028-bib-0098">98</xref> increase energy expenditure<xref ref-type="ref" rid="jcmm15028-bib-0099">99</xref> and increase insulin sensitivity.<xref ref-type="ref" rid="jcmm15028-bib-0100">100</xref> PPARγ activation could stimulate fatty acid oxidation in the liver.<xref ref-type="ref" rid="jcmm15028-bib-0101">101</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0102">102</xref> These are positive roles of PPARγ. At the same time, in vivo experiments for deletion or overexpression of PPARγ exhibited its prosteatotic role in the development of NAFLD or NASH.<xref ref-type="ref" rid="jcmm15028-bib-0103">103</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0104">104</xref>, <xref ref-type="ref" rid="jcmm15028-bib-0105">105</xref> PPARγ also regulates lipid deposition in liver and other tissues.<xref ref-type="ref" rid="jcmm15028-bib-0106">106</xref> Utilizing the positive effects of PPARγ while limiting its negative effects by targeting other PPARs has paved the way for the development of a new batch of dual and pan agonists. Some researchers have set their sights to natural dual and pan PPAR agonists. There are some cell studies showing that soy isoflavones exhibit antidiabetic and hypolipidemic effects by activating both PPARα and PPARγ.<xref ref-type="ref" rid="jcmm15028-bib-0107">107</xref> Guozhu<xref ref-type="ref" rid="jcmm15028-bib-0042">42</xref> reported that resveratrol suppresses oleate‐induced total cholesterol accumulation in macrophages by activating PPARα/γ signalling pathway, and it was confirmed that resveratrol could prevent hepatic steatosis in NAFLD.<xref ref-type="ref" rid="jcmm15028-bib-0108">108</xref> Polyphenolic compounds from different sources showed apparent effects on PPAR expression and affect lipid accumulation in high‐fat‐fed mice.<xref ref-type="ref" rid="jcmm15028-bib-0109">109</xref> Bavachinin is a natural pan PPAR agonist that increase effectiveness of TZDs or fibrates when regulating carbohydrate and lipid metabolism in diet‐induced obese mice.<xref ref-type="ref" rid="jcmm15028-bib-0110">110</xref>
</p>
</sec>
</sec>
<sec id="jcmm15028-sec-0009" sec-type="conclusions">
<label>5</label>
<title>CONCLUSION</title>
<p>Natural products have been and continue to be rich sources for drug discovery. Natural agonists of PPARγ have confirmed anti‐inflammatory, antioxidant properties, anti‐fibrosis, anti‐tumour and metabolism regulation effects. These beneficial effects may be partly due to the role of PPARγ in pathophysiological processes. Both experimental and clinical research results have indicated PPARγ agonists from natural products play vital roles in their protective effects in liver diseases. Besides, dual PPARα/γ or PPAR δ/γ agonists and pan agonists have draw researchers’ attention, and sometimes they have better curative effects.</p>
<p>However, the limitation of this review is that there are few studies on the treatment of liver diseases with PPARγ natural agonists. Because PPARγ and the target genes of natural products are diverse, it is likely that many other mechanisms contribute to their beneficial effects in these and other disease models. A lot of ongoing research efforts are trying to broaden our horizons to better understand the role of PPARγ systematically.</p>
</sec>
<sec id="jcmm15028-sec-0010" sec-type="COI-statement">
<title>CONFLICT OF INTERESTS</title>
<p>The authors report no conflicts of interest in the present study.</p>
</sec>
<sec id="jcmm15028-sec-0011">
<title>AUTHOR CONTRIBUTION</title>
<p>Liwei Wu wrote the manuscript and made the original tables and figures. Chuanyong Guo and Jianye Wu revised the manuscript and tables and figures. All authors read and approved the final manuscript.</p>
</sec>
</body>
<back>
<sec id="jcmm15028-sec-0013" sec-type="data-availability">
<title>DATA AVAILABILITY STATEMENT</title>
<p>All data included in this study are available.</p>
</sec>
<ref-list content-type="cited-references" id="jcmm15028-bibl-0001">
<title>REFERENCES</title>
<ref id="jcmm15028-bib-0001">
<label>1</label>
<mixed-citation id="jcmm15028-cit-0001" publication-type="journal">
<string-name>
<surname>Semple</surname>
<given-names>RK</given-names>
</string-name>, <string-name>
<surname>Chatterjee</surname>
<given-names>VK</given-names>
</string-name>, <string-name>
<surname>O'Rahilly</surname>
<given-names>S</given-names>
</string-name>. <article-title>PPAR gamma and human metabolic disease</article-title>. <source xml:lang="en"/>J Clin Invest. <year>2006</year>;<volume>116</volume>:<fpage>581</fpage>‐<lpage>589</lpage>.<pub-id pub-id-type="pmid">16511590</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0002">
<label>2</label>
<mixed-citation id="jcmm15028-cit-0002" publication-type="journal">
<string-name>
<surname>Hallenborg</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Petersen</surname>
<given-names>RK</given-names>
</string-name>, <string-name>
<surname>Kouskoumvekaki</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Newman</surname>
<given-names>JW</given-names>
</string-name>, <string-name>
<surname>Madsen</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Kristiansen</surname>
<given-names>K</given-names>
</string-name>. <article-title>The elusive endogenous adipogenic PPARgamma agonists: lining up the suspects</article-title>. <source xml:lang="en"/>Prog Lipid Res. <year>2016</year>;<volume>61</volume>:<fpage>149</fpage>‐<lpage>162</lpage>.<pub-id pub-id-type="pmid">26703188</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0003">
<label>3</label>
<mixed-citation id="jcmm15028-cit-0003" publication-type="journal">
<string-name>
<surname>Goto</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>YI</given-names>
</string-name>, <string-name>
<surname>Takahashi</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Kawada</surname>
<given-names>T</given-names>
</string-name>. <article-title>Natural compounds regulate energy metabolism by the modulating the activity of lipid‐sensing nuclear receptors</article-title>. <source xml:lang="en"/>Mol Nutr Food Res. <year>2013</year>;<volume>57</volume>:<fpage>20</fpage>‐<lpage>33</lpage>.<pub-id pub-id-type="pmid">23180608</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0004">
<label>4</label>
<mixed-citation id="jcmm15028-cit-0004" publication-type="journal">
<string-name>
<surname>Jia</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>G</given-names>
</string-name>, et al. <article-title>New insights into the PPAR gamma agonists for the treatment of diabetic nephropathy</article-title>. <source xml:lang="en"/>PPAR Res. <year>2014</year>;<volume>2014</volume>:<fpage>818530</fpage>.<pub-id pub-id-type="pmid">24624137</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0005">
<label>5</label>
<mixed-citation id="jcmm15028-cit-0005" publication-type="journal">
<string-name>
<surname>Chigurupati</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Dhanaraj</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Balakumar</surname>
<given-names>P</given-names>
</string-name>. <article-title>A step ahead of PPARgamma full agonists to PPARgamma partial agonists: therapeutic perspectives in the management of diabetic insulin resistance</article-title>. <source xml:lang="en"/>Eur J Pharmacol. <year>2015</year>;<volume>755</volume>:<fpage>50</fpage>‐<lpage>57</lpage>.<pub-id pub-id-type="pmid">25748601</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0006">
<label>6</label>
<mixed-citation id="jcmm15028-cit-0006" publication-type="journal">
<string-name>
<surname>Vallée</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Lecarpentier</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Guillevin</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Vallee</surname>
<given-names>JN</given-names>
</string-name>. <article-title>Demyelination in multiple sclerosis: reprogramming energy metabolism and potential PPARgamma agonist treatment approaches</article-title>. <source xml:lang="en"/>Int J Mol Sci. <year>2018</year>;<volume>19</volume>:<fpage>1212</fpage>.</mixed-citation>
</ref>
<ref id="jcmm15028-bib-0007">
<label>7</label>
<mixed-citation id="jcmm15028-cit-0007" publication-type="journal">
<string-name>
<surname>Zhao</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Yagiz</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Chung</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Marshall</surname>
<given-names>MR</given-names>
</string-name>. <article-title>Muscadine grape seed oil as a novel source of tocotrienols to reduce adipogenesis and adipocyte inflammation</article-title>. <source xml:lang="en"/>Food Funct. <year>2015</year>;<volume>6</volume>:<fpage>2293</fpage>‐<lpage>2302</lpage>.<pub-id pub-id-type="pmid">26073057</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0008">
<label>8</label>
<mixed-citation id="jcmm15028-cit-0008" publication-type="journal">
<string-name>
<surname>Nobs</surname>
<given-names>SP</given-names>
</string-name>, <string-name>
<surname>Kopf</surname>
<given-names>M</given-names>
</string-name>. <article-title>PPAR‐gamma in innate and adaptive lung immunity</article-title>. <source xml:lang="en"/>J Leukoc Biol. <year>2018</year>;<volume>104</volume>:<fpage>737</fpage>‐<lpage>741</lpage>.<pub-id pub-id-type="pmid">29768688</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0009">
<label>9</label>
<mixed-citation id="jcmm15028-cit-0009" publication-type="journal">
<string-name>
<surname>Chung</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Seo</surname>
<given-names>AY</given-names>
</string-name>, <string-name>
<surname>Chung</surname>
<given-names>SW</given-names>
</string-name>, et al. <article-title>Molecular mechanism of PPAR in the regulation of age‐related inflammation</article-title>. <source xml:lang="en"/>Ageing Res Rev. <year>2008</year>;<volume>7</volume>:<fpage>126</fpage>‐<lpage>136</lpage>.<pub-id pub-id-type="pmid">18313368</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0010">
<label>10</label>
<mixed-citation id="jcmm15028-cit-0010" publication-type="journal">
<string-name>
<surname>Abdelrahman</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sivarajah</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Thiemermann</surname>
<given-names>C</given-names>
</string-name>. <article-title>Beneficial effects of PPAR‐gamma ligands in ischemia‐reperfusion injury, inflammation and shock</article-title>. <source xml:lang="en"/>Cardiovasc Res. <year>2005</year>;<volume>65</volume>:<fpage>772</fpage>‐<lpage>781</lpage>.<pub-id pub-id-type="pmid">15721857</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0011">
<label>11</label>
<mixed-citation id="jcmm15028-cit-0011" publication-type="journal">
<string-name>
<surname>Giaginis</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Giagini</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Theocharis</surname>
<given-names>S</given-names>
</string-name>. <article-title>Peroxisome proliferator‐activated receptor‐gamma (PPAR‐gamma) ligands as potential therapeutic agents to treat arthritis</article-title>. <source xml:lang="en"/>Pharmacol Res. <year>2009</year>;<volume>60</volume>:<fpage>160</fpage>‐<lpage>169</lpage>.<pub-id pub-id-type="pmid">19646655</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0012">
<label>12</label>
<mixed-citation id="jcmm15028-cit-0012" publication-type="journal">
<string-name>
<surname>Staels</surname>
<given-names>B</given-names>
</string-name>. <article-title>PPARgamma and atherosclerosis</article-title>. <source xml:lang="en"/>Curr Med Res Opin. <year>2005</year>;<volume>21</volume>(<issue>suppl 1</issue>):<fpage>S13</fpage>‐<lpage>S20</lpage>.</mixed-citation>
</ref>
<ref id="jcmm15028-bib-0013">
<label>13</label>
<mixed-citation id="jcmm15028-cit-0013" publication-type="journal">
<string-name>
<surname>Reka</surname>
<given-names>AK</given-names>
</string-name>, <string-name>
<surname>Goswami</surname>
<given-names>MT</given-names>
</string-name>, <string-name>
<surname>Krishnapuram</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Standiford</surname>
<given-names>TJ</given-names>
</string-name>, <string-name>
<surname>Keshamouni</surname>
<given-names>VG</given-names>
</string-name>. <article-title>Molecular cross‐regulation between PPAR‐gamma and other signaling pathways: implications for lung cancer therapy</article-title>. <source xml:lang="en"/>Lung Cancer. <year>2011</year>;<volume>72</volume>:<fpage>154</fpage>‐<lpage>159</lpage>.<pub-id pub-id-type="pmid">21354647</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0014">
<label>14</label>
<mixed-citation id="jcmm15028-cit-0014" publication-type="journal">
<string-name>
<surname>Lecarpentier</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Claes</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Vallee</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Hebert</surname>
<given-names>JL</given-names>
</string-name>. <article-title>Interactions between PPAR gamma and the canonical Wnt/beta‐catenin pathway in type 2 diabetes and colon cancer</article-title>. <source xml:lang="en"/>PPAR Res. <year>2017</year>;<volume>2017</volume>:<fpage>5879090</fpage>.<pub-id pub-id-type="pmid">28298922</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0015">
<label>15</label>
<mixed-citation id="jcmm15028-cit-0015" publication-type="journal">
<string-name>
<surname>Heudobler</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Rechenmacher</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Luke</surname>
<given-names>F</given-names>
</string-name>, et al. <article-title>Peroxisome proliferator‐activated receptors (PPAR)gamma agonists as master modulators of tumor tissue</article-title>. <source xml:lang="en"/>Int J Mol Sci. <year>2018</year>;<volume>19</volume>:<fpage>3540</fpage>.</mixed-citation>
</ref>
<ref id="jcmm15028-bib-0016">
<label>16</label>
<mixed-citation id="jcmm15028-cit-0016" publication-type="journal">
<string-name>
<surname>Li</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Dong</surname>
<given-names>L</given-names>
</string-name>, et al. <article-title>Morusin suppresses breast cancer cell growth in vitro and in vivo through C/EBPbeta and PPARgamma mediated lipoapoptosis</article-title>. <source xml:lang="en"/>J Exp Clin Cancer Res. <year>2015</year>;<volume>34</volume>:<fpage>137</fpage>.<pub-id pub-id-type="pmid">26538209</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0017">
<label>17</label>
<mixed-citation id="jcmm15028-cit-0017" publication-type="journal">
<string-name>
<surname>Zheng</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Dai</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>W</given-names>
</string-name>, et al. <article-title>Astragaloside IV enhances taxol chemosensitivity of breast cancer via caveolin‐1‐targeting oxidant damage</article-title>. <source xml:lang="en"/>J Cell Physiol. <year>2019</year>;<volume>234</volume>:<fpage>4277</fpage>‐<lpage>4290</lpage>.<pub-id pub-id-type="pmid">30146689</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0018">
<label>18</label>
<mixed-citation id="jcmm15028-cit-0018" publication-type="journal">
<string-name>
<surname>Vitale</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Zappavigna</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Marra</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>The PPAR‐gamma agonist troglitazone antagonizes survival pathways induced by STAT‐3 in recombinant interferon‐beta treated pancreatic cancer cells</article-title>. <source xml:lang="en"/>Biotechnol Adv. <year>2012</year>;<volume>30</volume>:<fpage>169</fpage>‐<lpage>184</lpage>.<pub-id pub-id-type="pmid">21871555</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0019">
<label>19</label>
<mixed-citation id="jcmm15028-cit-0019" publication-type="journal">
<string-name>
<surname>Tan</surname>
<given-names>BS</given-names>
</string-name>, <string-name>
<surname>Kang</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Mai</surname>
<given-names>CW</given-names>
</string-name>, et al. <article-title>6‐Shogaol inhibits breast and colon cancer cell proliferation through activation of peroxisomal proliferator activated receptor gamma (PPARgamma)</article-title>. <source xml:lang="en"/>Cancer Lett. <year>2013</year>;<volume>336</volume>:<fpage>127</fpage>‐<lpage>139</lpage>.<pub-id pub-id-type="pmid">23612072</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0020">
<label>20</label>
<mixed-citation id="jcmm15028-cit-0020" publication-type="journal">
<string-name>
<surname>Yasui</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Hosokawa</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sahara</surname>
<given-names>T</given-names>
</string-name>, et al. <article-title>Bitter gourd seed fatty acid rich in 9c,11t,13t‐conjugated linolenic acid induces apoptosis and up‐regulates the GADD45, p53 and PPARgamma in human colon cancer Caco‐2 cells</article-title>. <source xml:lang="en"/>Prostaglandins Leukot Essent Fatty Acids. <year>2005</year>;<volume>73</volume>:<fpage>113</fpage>‐<lpage>119</lpage>.<pub-id pub-id-type="pmid">15961301</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0021">
<label>21</label>
<mixed-citation id="jcmm15028-cit-0021" publication-type="journal">
<string-name>
<surname>Sato</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ishihara</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kawashima</surname>
<given-names>K</given-names>
</string-name>, et al. <article-title>Expression of peroxisome proliferator‐activated receptor (PPAR)gamma in gastric cancer and inhibitory effects of PPARgamma agonists</article-title>. <source xml:lang="en"/>Br J Cancer. <year>2000</year>;<volume>83</volume>:<fpage>1394</fpage>‐<lpage>1400</lpage>.<pub-id pub-id-type="pmid">11044367</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0022">
<label>22</label>
<mixed-citation id="jcmm15028-cit-0022" publication-type="journal">
<string-name>
<surname>Kawai</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Masaki</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Doi</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>PPAR‐gamma agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF‐beta</article-title>. <source xml:lang="en"/>Lab Invest. <year>2009</year>;<volume>89</volume>:<fpage>47</fpage>‐<lpage>58</lpage>.<pub-id pub-id-type="pmid">19002105</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0023">
<label>23</label>
<mixed-citation id="jcmm15028-cit-0023" publication-type="journal">
<string-name>
<surname>Wei</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Komura</surname>
<given-names>K</given-names>
</string-name>, et al. <article-title>A synthetic PPAR‐gamma agonist triterpenoid ameliorates experimental fibrosis: PPAR‐gamma‐independent suppression of fibrotic responses</article-title>. <source xml:lang="en"/>Ann Rheum Dis. <year>2014</year>;<volume>73</volume>:<fpage>446</fpage>‐<lpage>454</lpage>.<pub-id pub-id-type="pmid">23515440</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0024">
<label>24</label>
<mixed-citation id="jcmm15028-cit-0024" publication-type="journal">
<string-name>
<surname>Kumar</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Mundra</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Mahato</surname>
<given-names>RI</given-names>
</string-name>. <article-title>Nanomedicines of Hedgehog inhibitor and PPAR‐gamma agonist for treating liver fibrosis</article-title>. <source xml:lang="en"/>Pharm Res. <year>2014</year>;<volume>31</volume>:<fpage>1158</fpage>‐<lpage>1169</lpage>.<pub-id pub-id-type="pmid">24249038</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0025">
<label>25</label>
<mixed-citation id="jcmm15028-cit-0025" publication-type="journal">
<string-name>
<surname>Dantas</surname>
<given-names>AT</given-names>
</string-name>, <string-name>
<surname>Pereira</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>de Melo Rego</surname>
<given-names>MJB</given-names>
</string-name>, et al. <article-title>The role of PPAR gamma in systemic sclerosis</article-title>. <source xml:lang="en"/>PPAR Res. <year>2015</year>;<volume>2015</volume>:<fpage>124624</fpage>.<pub-id pub-id-type="pmid">26064084</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0026">
<label>26</label>
<mixed-citation id="jcmm15028-cit-0026" publication-type="journal">
<string-name>
<surname>Ichiro Takada</surname>
<given-names>MM</given-names>
</string-name>. <article-title>PPARg ligands and their therapeutic applications: a patent review (2008–2014)</article-title>. <source xml:lang="en"/>Expert Opin Ther Pat. <year>2015</year>;<volume>25</volume>:<fpage>175</fpage>‐<lpage>191</lpage>.<pub-id pub-id-type="pmid">25416646</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0027">
<label>27</label>
<mixed-citation id="jcmm15028-cit-0027" publication-type="journal">
<string-name>
<surname>Matsuda</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Nakamura</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Yoshikawa</surname>
<given-names>M</given-names>
</string-name>. <article-title>Search for new type of PPARγ agonist‐like anti‐diabetic compounds from medicinal plants</article-title>. <source xml:lang="en"/>Biol Pharm Bull. <year>2014</year>;<volume>37</volume>:<fpage>884</fpage>‐<lpage>891</lpage>.<pub-id pub-id-type="pmid">24882400</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0028">
<label>28</label>
<mixed-citation id="jcmm15028-cit-0028" publication-type="journal">
<string-name>
<surname>Wang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Waltenberger</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Pferschy‐Wenzig</surname>
<given-names>EM</given-names>
</string-name>, et al. <article-title>Natural product agonists of peroxisome proliferator‐activated receptor gamma (PPARgamma): a review</article-title>. <source xml:lang="en"/>Biochem Pharmacol. <year>2014</year>;<volume>92</volume>:<fpage>73</fpage>‐<lpage>89</lpage>.<pub-id pub-id-type="pmid">25083916</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0029">
<label>29</label>
<mixed-citation id="jcmm15028-cit-0029" publication-type="journal">
<string-name>
<surname>del Bas</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Laos</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Caimari</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Crescenti</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Arola</surname>
<given-names>L</given-names>
</string-name>. <article-title>Detection of bioavailable peroxisome proliferator‐activated receptor gamma modulators by a cell‐based luciferase reporter system</article-title>. <source xml:lang="en"/>Anal Biochem. <year>2012</year>;<volume>427</volume>:<fpage>187</fpage>‐<lpage>189</lpage>.<pub-id pub-id-type="pmid">22613053</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0030">
<label>30</label>
<mixed-citation id="jcmm15028-cit-0030" publication-type="journal">
<string-name>
<surname>Petersen</surname>
<given-names>RK</given-names>
</string-name>, <string-name>
<surname>Christensen</surname>
<given-names>KB</given-names>
</string-name>, <string-name>
<surname>Assimopoulou</surname>
<given-names>AN</given-names>
</string-name>, et al. <article-title>Pharmacophore‐driven identification of PPARgamma agonists from natural sources</article-title>. <source xml:lang="en"/>J Comput Aided Mol Des. <year>2011</year>;<volume>25</volume>:<fpage>107</fpage>‐<lpage>116</lpage>.<pub-id pub-id-type="pmid">21069556</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0031">
<label>31</label>
<mixed-citation id="jcmm15028-cit-0031" publication-type="journal">
<string-name>
<surname>Peng</surname>
<given-names>YH</given-names>
</string-name>, <string-name>
<surname>Coumar</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Leou</surname>
<given-names>JS</given-names>
</string-name>, et al. <article-title>Structural basis for the improved potency of peroxisome proliferator‐activated receptor (PPAR) agonists</article-title>. <source xml:lang="en"/>ChemMedChem. <year>2010</year>;<volume>5</volume>:<fpage>1707</fpage>‐<lpage>1716</lpage>.<pub-id pub-id-type="pmid">20734309</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0032">
<label>32</label>
<mixed-citation id="jcmm15028-cit-0032" publication-type="journal">
<string-name>
<surname>Jang</surname>
<given-names>JY</given-names>
</string-name>, <string-name>
<surname>Koh</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Bae</surname>
<given-names>H</given-names>
</string-name>, et al. <article-title>Structural basis for differential activities of enantiomeric PPARgamma agonists: binding of S35 to the alternate site</article-title>. <source xml:lang="en"/>Biochim Biophys Acta. <year>2017</year>;<volume>1865</volume>:<fpage>674</fpage>‐<lpage>681</lpage>.</mixed-citation>
</ref>
<ref id="jcmm15028-bib-0033">
<label>33</label>
<mixed-citation id="jcmm15028-cit-0033" publication-type="journal">
<string-name>
<surname>Salam</surname>
<given-names>NK</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>TH</given-names>
</string-name>, <string-name>
<surname>Kota</surname>
<given-names>BP</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Hibbs</surname>
<given-names>DE</given-names>
</string-name>. <article-title>Novel PPAR‐gamma agonists identified from a natural product library: a virtual screening, induced‐fit docking and biological assay study</article-title>. <source xml:lang="en"/>Chem Biol Drug Des. <year>2008</year>;<volume>71</volume>:<fpage>57</fpage>‐<lpage>70</lpage>.<pub-id pub-id-type="pmid">18086153</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0034">
<label>34</label>
<mixed-citation id="jcmm15028-cit-0034" publication-type="journal">
<string-name>
<surname>Al Sharif</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Alov</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Diukendjieva</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Molecular determinants of PPARgamma partial agonism and related in silico/in vivo studies of natural saponins as potential type 2 diabetes modulators</article-title>. <source xml:lang="en"/>Food Chem Toxicol. <year>2018</year>;<volume>112</volume>:<fpage>47</fpage>‐<lpage>59</lpage>.<pub-id pub-id-type="pmid">29247773</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0035">
<label>35</label>
<mixed-citation id="jcmm15028-cit-0035" publication-type="journal">
<string-name>
<surname>Porskjaer Christensen</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Bahij</surname>
<given-names>E‐H</given-names>
</string-name>. <article-title>Development of an in vitro screening platform for the identification of partial PPARgamma agonists as a source for antidiabetic lead compounds</article-title>. <source xml:lang="en"/>Molecules. <year>2018</year>;<volume>23</volume>:<fpage>2431</fpage>.</mixed-citation>
</ref>
<ref id="jcmm15028-bib-0036">
<label>36</label>
<mixed-citation id="jcmm15028-cit-0036" publication-type="journal">
<string-name>
<surname>Maltarollo</surname>
<given-names>VG</given-names>
</string-name>, <string-name>
<surname>Togashi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Nascimento</surname>
<given-names>AS</given-names>
</string-name>, <string-name>
<surname>Honorio</surname>
<given-names>KM</given-names>
</string-name>. <article-title>Structure‐based virtual screening and discovery of New PPARdelta/gamma dual agonist and PPARdelta and gamma agonists</article-title>. <source xml:lang="en"/>PLoS ONE. <year>2015</year>;<volume>10</volume>:<elocation-id>e0118790</elocation-id>.<pub-id pub-id-type="pmid">25767888</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0037">
<label>37</label>
<mixed-citation id="jcmm15028-cit-0037" publication-type="journal">
<string-name>
<surname>Vidovic</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Busby</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Griffin</surname>
<given-names>PR</given-names>
</string-name>, <string-name>
<surname>Schurer</surname>
<given-names>SC</given-names>
</string-name>. <article-title>A combined ligand‐ and structure‐based virtual screening protocol identifies submicromolar PPARgamma partial agonists</article-title>. <source xml:lang="en"/>ChemMedChem. <year>2011</year>;<volume>6</volume>:<fpage>94</fpage>‐<lpage>103</lpage>.<pub-id pub-id-type="pmid">21162086</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0038">
<label>38</label>
<mixed-citation id="jcmm15028-cit-0038" publication-type="journal">
<string-name>
<surname>El‐Houri</surname>
<given-names>RB</given-names>
</string-name>, <string-name>
<surname>Mortier</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Murgueitio</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Wolber</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Christensen</surname>
<given-names>LP</given-names>
</string-name>. <article-title>Identification of PPARgamma agonists from natural sources using different in silico approaches</article-title>. <source xml:lang="en"/>Planta Med. <year>2015</year>;<volume>81</volume>:<fpage>488</fpage>‐<lpage>494</lpage>.<pub-id pub-id-type="pmid">25251562</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0039">
<label>39</label>
<mixed-citation id="jcmm15028-cit-0039" publication-type="journal">
<string-name>
<surname>Balakumar</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Rose</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ganti</surname>
<given-names>SS</given-names>
</string-name>, <string-name>
<surname>Krishan</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Singh</surname>
<given-names>M</given-names>
</string-name>. <article-title>PPAR dual agonists: are they opening Pandora's Box?</article-title>
<source xml:lang="en"/>Pharmacol Res. <year>2007</year>;<volume>56</volume>:<fpage>91</fpage>‐<lpage>98</lpage>.<pub-id pub-id-type="pmid">17428674</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0040">
<label>40</label>
<mixed-citation id="jcmm15028-cit-0040" publication-type="journal">
<string-name>
<surname>Duran‐Sandoval</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Thomas</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Bailleul</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Fruchart</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Staels</surname>
<given-names>B</given-names>
</string-name>. <article-title>Pharmacology of PPARalpha, PPARgamma and dual PPARalpha/gamma agonists in clinical development</article-title>. <source xml:lang="en"/>Med Sci (Paris). <year>2003</year>;<volume>19</volume>:<fpage>819</fpage>‐<lpage>825</lpage>.<pub-id pub-id-type="pmid">14593612</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0041">
<label>41</label>
<mixed-citation id="jcmm15028-cit-0041" publication-type="journal">
<string-name>
<surname>Rubenstrunk</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Hanf</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Hum</surname>
<given-names>DW</given-names>
</string-name>, <string-name>
<surname>Fruchart</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Staels</surname>
<given-names>B</given-names>
</string-name>. <article-title>Safety issues and prospects for future generations of PPAR modulators</article-title>. <source xml:lang="en"/>Biochim Biophys Acta. <year>2007</year>;<volume>1771</volume>:<fpage>1065</fpage>‐<lpage>1081</lpage>.<pub-id pub-id-type="pmid">17428730</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0042">
<label>42</label>
<mixed-citation id="jcmm15028-cit-0042" publication-type="journal">
<string-name>
<surname>Ye</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Gao</surname>
<given-names>H</given-names>
</string-name>, et al. <article-title>Resveratrol inhibits lipid accumulation in the intestine of atherosclerotic mice and macrophages</article-title>. <source xml:lang="en"/>J Cell Mol Med. <year>2019</year>;<volume>23</volume>:<fpage>4313</fpage>‐<lpage>4325</lpage>.<pub-id pub-id-type="pmid">30957417</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0043">
<label>43</label>
<mixed-citation id="jcmm15028-cit-0043" publication-type="journal">
<string-name>
<surname>Hotta</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Nakata</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Katsukawa</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hori</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Takahashi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Inoue</surname>
<given-names>H</given-names>
</string-name>. <article-title>Carvacrol, a component of thyme oil, activates PPARα and γ and suppress COX‐2 expression</article-title>. <source xml:lang="en"/>J Lipid Res. <year>2001</year>;<volume>51</volume>:<fpage>132</fpage>‐<lpage>139</lpage>.</mixed-citation>
</ref>
<ref id="jcmm15028-bib-0044">
<label>44</label>
<mixed-citation id="jcmm15028-cit-0044" publication-type="journal">
<string-name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Xie</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Xue</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Gu</surname>
<given-names>Z</given-names>
</string-name>. <article-title>Osthole improves fat milk‐induced fatty liver in rats: modulation of hepatic PPAR‐alpha/gamma‐mediated lipogenic gene expression</article-title>. <source xml:lang="en"/>Planta Med. <year>2007</year>;<volume>73</volume>:<fpage>718</fpage>‐<lpage>724</lpage>.<pub-id pub-id-type="pmid">17611927</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0045">
<label>45</label>
<mixed-citation id="jcmm15028-cit-0045" publication-type="journal">
<string-name>
<surname>Song</surname>
<given-names>LB</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>ZH</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>KB</given-names>
</string-name>. <article-title>Study on activity of dark tea extracts on PPARs model</article-title>. <source xml:lang="en"/>J Tea Sci. <year>2008</year>;<volume>28</volume>:<fpage>319</fpage>‐<lpage>325</lpage>.</mixed-citation>
</ref>
<ref id="jcmm15028-bib-0046">
<label>46</label>
<mixed-citation id="jcmm15028-cit-0046" publication-type="journal">
<string-name>
<surname>Nobuyuki Takahashi</surname>
<given-names>TK</given-names>
</string-name>, <string-name>
<surname>Goto</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Yamamoto</surname>
<given-names>T</given-names>
</string-name>, et al. <article-title>Dual action of isoprenols from herbal medicines on both PPARγ and PPARu in 3T3‐L1 adipocytes and HepG2 hepatocytes</article-title>. <source xml:lang="en"/>FEBS Lett. <year>2002</year>;<volume>514</volume>:<fpage>315</fpage>‐<lpage>322</lpage>.<pub-id pub-id-type="pmid">11943173</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0047">
<label>47</label>
<mixed-citation id="jcmm15028-cit-0047" publication-type="journal">
<string-name>
<surname>Maisa</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Jardat</surname>
<given-names>DJN</given-names>
</string-name>, <string-name>
<surname>Baogen</surname>
<given-names>WU</given-names>
</string-name>, <string-name>
<surname>Avery</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Feller</surname>
<given-names>DR</given-names>
</string-name>. <article-title>Pseudolaric acid analogs as a new class of peroxisome proliferator‐activated receptor agonists</article-title>. <source xml:lang="en"/>Planta Med. <year>2002</year>;<volume>68</volume>:<fpage>666</fpage>‐<lpage>671</lpage>.</mixed-citation>
</ref>
<ref id="jcmm15028-bib-0048">
<label>48</label>
<mixed-citation id="jcmm15028-cit-0048" publication-type="journal">
<string-name>
<surname>Park</surname>
<given-names>MY</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>KS</given-names>
</string-name>, <string-name>
<surname>Sung</surname>
<given-names>MK</given-names>
</string-name>. <article-title>Effects of dietary mulberry, Korean red ginseng, and banaba on glucose homeostasis in relation to PPAR‐alpha, PPAR‐gamma, and LPL mRNA expressions</article-title>. <source xml:lang="en"/>Life Sci. <year>2005</year>;<volume>77</volume>:<fpage>3344</fpage>‐<lpage>3354</lpage>.<pub-id pub-id-type="pmid">15979095</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0049">
<label>49</label>
<mixed-citation id="jcmm15028-cit-0049" publication-type="journal">
<string-name>
<surname>O'Sullivan</surname>
<given-names>SE</given-names>
</string-name>. <article-title>An update on PPAR activation by cannabinoids</article-title>. <source xml:lang="en"/>Br J Pharmacol. <year>2016</year>;<volume>173</volume>:<fpage>1899</fpage>‐<lpage>1910</lpage>.<pub-id pub-id-type="pmid">27077495</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0050">
<label>50</label>
<mixed-citation id="jcmm15028-cit-0050" publication-type="journal">
<string-name>
<surname>Rogue</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Spire</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Brun</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Claude</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Guillouzo</surname>
<given-names>A</given-names>
</string-name>. <article-title>Gene expression changes induced by PPAR gamma agonists in animal and human liver</article-title>. <source xml:lang="en"/>PPAR Res. <year>2010</year>;<volume>2010</volume>:<fpage>325183</fpage>.<pub-id pub-id-type="pmid">20981297</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0051">
<label>51</label>
<mixed-citation id="jcmm15028-cit-0051" publication-type="journal">
<string-name>
<surname>Wu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>T</given-names>
</string-name>, et al. <article-title>Quercetin shows anti‐tumor effect in hepatocellular carcinoma LM3 cells by abrogating JAK2/STAT3 signaling pathway</article-title>. <source xml:lang="en"/>Cancer Med. <year>2019</year>;<volume>8</volume>:<fpage>4806</fpage>‐<lpage>4820</lpage>.<pub-id pub-id-type="pmid">31273958</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0052">
<label>52</label>
<mixed-citation id="jcmm15028-cit-0052" publication-type="journal">
<string-name>
<surname>Wu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Hepatoprotective effect of quercetin via TRAF6/JNK pathway in acute hepatitis</article-title>. <source xml:lang="en"/>Biomed Pharmacother. <year>2017</year>;<volume>96</volume>:<fpage>1137</fpage>‐<lpage>1146</lpage>.<pub-id pub-id-type="pmid">29174851</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0053">
<label>53</label>
<mixed-citation id="jcmm15028-cit-0053" publication-type="journal">
<string-name>
<surname>Wu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Dai</surname>
<given-names>W</given-names>
</string-name>, et al. <article-title>Quercetin pretreatment attenuates hepatic ischemia reperfusion‐induced apoptosis and autophagy by inhibiting ERK/NF‐kappaB pathway</article-title>. <source xml:lang="en"/>Gastroenterol Res Pract. <year>2017</year>;<volume>2017</volume>:<fpage>9724217</fpage>.<pub-id pub-id-type="pmid">29123547</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0054">
<label>54</label>
<mixed-citation id="jcmm15028-cit-0054" publication-type="journal">
<string-name>
<surname>Wang</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Alleviation of hepatic ischemia reperfusion injury by oleanolic acid pretreating via reducing HMGB1 release and inhibiting apoptosis and autophagy</article-title>. <source xml:lang="en"/>Mediators Inflamm. <year>2019</year>;<volume>2019</volume>:<fpage>3240713</fpage>.<pub-id pub-id-type="pmid">31316298</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0055">
<label>55</label>
<mixed-citation id="jcmm15028-cit-0055" publication-type="journal">
<string-name>
<surname>Feng</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>T</given-names>
</string-name>, et al. <article-title>Procyanidin B2 inhibits the activation of hepatic stellate cells and angiogenesis via the Hedgehog pathway during liver fibrosis</article-title>. <source xml:lang="en"/>J Cell Mol Med. <year>2019</year>;<volume>23</volume>(<issue>9</issue>):<fpage>6479</fpage>‐<lpage>6493</lpage>.<pub-id pub-id-type="pmid">31328391</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0056">
<label>56</label>
<mixed-citation id="jcmm15028-cit-0056" publication-type="journal">
<string-name>
<surname>Li</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Feng</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>In vitro and in vivo study of epigallocatechin‐3‐gallate‐induced apoptosis in aerobic glycolytic hepatocellular carcinoma cells involving inhibition of phosphofructokinase activity</article-title>. <source xml:lang="en"/>Sci Rep. <year>2016</year>;<volume>6</volume>:<fpage>28479</fpage>.<pub-id pub-id-type="pmid">27349173</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0057">
<label>57</label>
<mixed-citation id="jcmm15028-cit-0057" publication-type="journal">
<string-name>
<surname>Lu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>K</given-names>
</string-name>, et al. <article-title>Isorhamnetin: a hepatoprotective flavonoid inhibits apoptosis and autophagy via P38/PPAR‐alpha pathway in mice</article-title>. <source xml:lang="en"/>Biomed Pharmacother. <year>2018</year>;<volume>103</volume>:<fpage>800</fpage>‐<lpage>811</lpage>.<pub-id pub-id-type="pmid">29684859</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0058">
<label>58</label>
<mixed-citation id="jcmm15028-cit-0058" publication-type="journal">
<string-name>
<surname>Li</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Dai</surname>
<given-names>W</given-names>
</string-name>, et al. <article-title>Genistein suppresses aerobic glycolysis and induces hepatocellular carcinoma cell death</article-title>. <source xml:lang="en"/>Br J Cancer. <year>2017</year>;<volume>117</volume>:<fpage>1518</fpage>‐<lpage>1528</lpage>.<pub-id pub-id-type="pmid">28926527</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0059">
<label>59</label>
<mixed-citation id="jcmm15028-cit-0059" publication-type="journal">
<string-name>
<surname>Szeles</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Torocsik</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Nagy</surname>
<given-names>L</given-names>
</string-name>. <article-title>PPARgamma in immunity and inflammation: cell types and diseases</article-title>. <source xml:lang="en"/>Biochem Biophys Acta. <year>2007</year>;<volume>1771</volume>:<fpage>1014</fpage>‐<lpage>1030</lpage>.<pub-id pub-id-type="pmid">17418635</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0060">
<label>60</label>
<mixed-citation id="jcmm15028-cit-0060" publication-type="journal">
<string-name>
<surname>El‐Sheikh</surname>
<given-names>AA</given-names>
</string-name>, <string-name>
<surname>Rifaai</surname>
<given-names>RA</given-names>
</string-name>. <article-title>Peroxisome proliferator activator receptor (PPAR)‐ gamma ligand, but not PPAR‐ alpha, ameliorates cyclophosphamide‐induced oxidative stress and inflammation in rat liver</article-title>. <source xml:lang="en"/>PPAR Res. <year>2014</year>;<volume>2014</volume>:<fpage>626319</fpage>.<pub-id pub-id-type="pmid">24803924</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0061">
<label>61</label>
<mixed-citation id="jcmm15028-cit-0061" publication-type="journal">
<string-name>
<surname>Murphy</surname>
<given-names>GJ</given-names>
</string-name>, <string-name>
<surname>Holder</surname>
<given-names>JC</given-names>
</string-name>
<article-title>PPAR‐gamma agonists: therapeutic role in diabetes, inflammation and cancer</article-title>. <source xml:lang="en"/>Trends Pharmacol Sci. <year>2000</year>;<volume>21</volume>:<fpage>469</fpage>‐<lpage>474</lpage>.<pub-id pub-id-type="pmid">11121836</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0062">
<label>62</label>
<mixed-citation id="jcmm15028-cit-0062" publication-type="journal">
<string-name>
<surname>Croasdell</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Duffney</surname>
<given-names>PF</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Lacy</surname>
<given-names>SH</given-names>
</string-name>, <string-name>
<surname>Sime</surname>
<given-names>PJ</given-names>
</string-name>, <string-name>
<surname>Phipps</surname>
<given-names>RP</given-names>
</string-name>. <article-title>PPARgamma and the innate immune system mediate the resolution of inflammation</article-title>. <source xml:lang="en"/>PPAR Res. <year>2015</year>;<volume>2015</volume>:<fpage>549691</fpage>.<pub-id pub-id-type="pmid">26713087</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0063">
<label>63</label>
<mixed-citation id="jcmm15028-cit-0063" publication-type="journal">
<string-name>
<surname>Chen</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>15‐Deoxy‐ gamma 12,14‐prostaglandin J2 reduces liver impairment in a model of ConA‐induced acute hepatic inflammation by activation of PPAR gamma and reduction in NF‐ kappa B activity</article-title>. <source xml:lang="en"/>PPAR Res. <year>2014</year>;<volume>2014</volume>:<fpage>215631</fpage>.<pub-id pub-id-type="pmid">25120564</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0064">
<label>64</label>
<mixed-citation id="jcmm15028-cit-0064" publication-type="journal">
<string-name>
<surname>Wang</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>RJ</given-names>
</string-name>, et al. <article-title>Apigenin protects against alcohol‐induced liver injury in mice by regulating hepatic CYP2E1‐mediated oxidative stress and PPARalpha‐mediated lipogenic gene expression</article-title>. <source xml:lang="en"/>Chem Biol Interact. <year>2017</year>;<volume>275</volume>:<fpage>171</fpage>‐<lpage>177</lpage>.<pub-id pub-id-type="pmid">28803762</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0065">
<label>65</label>
<mixed-citation id="jcmm15028-cit-0065" publication-type="journal">
<string-name>
<surname>Feng</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Weng</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>F</given-names>
</string-name>, et al. <article-title>Activation of PPARgamma by a natural flavonoid modulator, apigenin ameliorates obesity‐related inflammation via regulation of macrophage polarization</article-title>. <source xml:lang="en"/>EBioMedicine. <year>2016</year>;<volume>9</volume>:<fpage>61</fpage>‐<lpage>76</lpage>.<pub-id pub-id-type="pmid">27374313</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0066">
<label>66</label>
<mixed-citation id="jcmm15028-cit-0066" publication-type="journal">
<string-name>
<surname>Mahmoud</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Mohammed</surname>
<given-names>HM</given-names>
</string-name>, <string-name>
<surname>Khadrawy</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Galaly</surname>
<given-names>SR</given-names>
</string-name>. <article-title>Hesperidin protects against chemically induced hepatocarcinogenesis via modulation of Nrf2/ARE/HO‐1, PPARgamma and TGF‐beta1/Smad3 signaling, and amelioration of oxidative stress and inflammation</article-title>. <source xml:lang="en"/>Chem Biol Interact. <year>2017</year>;<volume>277</volume>:<fpage>146</fpage>‐<lpage>158</lpage>.<pub-id pub-id-type="pmid">28935427</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0067">
<label>67</label>
<mixed-citation id="jcmm15028-cit-0067" publication-type="journal">
<string-name>
<surname>Chen</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Ding</surname>
<given-names>HW</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>HD</given-names>
</string-name>, et al. <article-title>Hesperetin derivative‐14 alleviates inflammation by activating PPAR‐gamma in mice with CCl4‐induced acute liver injury and LPS‐treated RAW264.7 cells</article-title>. <source xml:lang="en"/>Toxicol Lett. <year>2017</year>;<volume>274</volume>:<fpage>51</fpage>‐<lpage>63</lpage>.<pub-id pub-id-type="pmid">28428136</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0068">
<label>68</label>
<mixed-citation id="jcmm15028-cit-0068" publication-type="journal">
<string-name>
<surname>El‐Naggar</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Al‐Joufi</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Anwar</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Attia</surname>
<given-names>MF</given-names>
</string-name>, <string-name>
<surname>El‐Bana</surname>
<given-names>MA</given-names>
</string-name>. <article-title>Curcumin‐loaded PLA‐PEG copolymer nanoparticles for treatment of liver inflammation in streptozotocin‐induced diabetic rats</article-title>. <source xml:lang="en"/>Colloids Surf B Biointerfaces. <year>2019</year>;<volume>177</volume>:<fpage>389</fpage>‐<lpage>398</lpage>.<pub-id pub-id-type="pmid">30785036</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0069">
<label>69</label>
<mixed-citation id="jcmm15028-cit-0069" publication-type="journal">
<string-name>
<surname>Liu</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Su</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Song</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Hong</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Chung</surname>
<given-names>HY</given-names>
</string-name>, <string-name>
<surname>Jung</surname>
<given-names>JH</given-names>
</string-name>. <article-title>An anti‐inflammatory PPAR‐gamma agonist from the jellyfish‐derived fungus <italic>Penicillium chrysogenum</italic> J08NF‐4</article-title>. <source xml:lang="en"/>J Nat Prod. <year>2018</year>;<volume>81</volume>:<fpage>356</fpage>‐<lpage>363</lpage>.<pub-id pub-id-type="pmid">29389121</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0070">
<label>70</label>
<mixed-citation id="jcmm15028-cit-0070" publication-type="journal">
<string-name>
<surname>Zhang</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Kong</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zheng</surname>
<given-names>S</given-names>
</string-name>. <article-title>Peroxisome proliferator‐activated receptor‐gamma as a therapeutic target for hepatic fibrosis: from bench to bedside</article-title>. <source xml:lang="en"/>Cell Mol Life Sci. <year>2013</year>;<volume>70</volume>:<fpage>259</fpage>‐<lpage>276</lpage>.<pub-id pub-id-type="pmid">22699820</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0071">
<label>71</label>
<mixed-citation id="jcmm15028-cit-0071" publication-type="journal">
<string-name>
<surname>Zheng</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>A</given-names>
</string-name>. <article-title>Curcumin suppresses the expression of extracellular matrix genes in activated hepatic stellate cells by inhibiting gene expression of connective tissue growth factor</article-title>. <source xml:lang="en"/>Am J Physiol Gastrointest Liver Physiol. <year>2006</year>;<volume>290</volume>:<fpage>G883</fpage>‐<lpage>G893</lpage>.<pub-id pub-id-type="pmid">16306131</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0072">
<label>72</label>
<mixed-citation id="jcmm15028-cit-0072" publication-type="journal">
<string-name>
<surname>Zheng</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>A</given-names>
</string-name>. <article-title>Disruption of transforming growth factor‐beta signaling by curcumin induces gene expression of peroxisome proliferator‐activated receptor in rat hepatic stellate cells</article-title>. <source xml:lang="en"/>Am J Physiol Gastrointest Liver Physiol. <year>2006</year>;<volume>292</volume>:<fpage>G113</fpage>‐<lpage>G123</lpage>.<pub-id pub-id-type="pmid">16959952</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0073">
<label>73</label>
<mixed-citation id="jcmm15028-cit-0073" publication-type="journal">
<string-name>
<surname>Guo</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>He</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Liang</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Duan</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>R</given-names>
</string-name>. <article-title>Anti‐fibrotic effects of puerarin on CCl4‐induced hepatic fibrosis in rats possibly through the regulation of PPAR‐gamma expression and inhibition of PI3K/Akt pathway</article-title>. <source xml:lang="en"/>Food Chem Toxicol. <year>2013</year>;<volume>56</volume>:<fpage>436</fpage>‐<lpage>442</lpage>.<pub-id pub-id-type="pmid">23500774</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0074">
<label>74</label>
<mixed-citation id="jcmm15028-cit-0074" publication-type="journal">
<string-name>
<surname>Hsu</surname>
<given-names>WH</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>BH</given-names>
</string-name>, <string-name>
<surname>Hsu</surname>
<given-names>YW</given-names>
</string-name>, <string-name>
<surname>Pan</surname>
<given-names>TM</given-names>
</string-name>. <article-title>Peroxisome proliferator‐activated receptor‐gamma activators monascin and rosiglitazone attenuate carboxymethyllysine‐induced fibrosis in hepatic stellate cells through regulating the oxidative stress pathway but independent of the receptor for advanced glycation end products signaling</article-title>. <source xml:lang="en"/>J Agric Food Chem. <year>2013</year>;<volume>61</volume>:<fpage>6873</fpage>‐<lpage>6879</lpage>.<pub-id pub-id-type="pmid">23796251</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0075">
<label>75</label>
<mixed-citation id="jcmm15028-cit-0075" publication-type="journal">
<string-name>
<surname>Choi</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Jin</surname>
<given-names>SW</given-names>
</string-name>, <string-name>
<surname>Choi</surname>
<given-names>CY</given-names>
</string-name>, et al. <article-title>Capsaicin inhibits dimethylnitrosamine‐induced hepatic fibrosis by inhibiting the TGF‐beta1/Smad pathway via peroxisome proliferator‐activated receptor gamma activation</article-title>. <source xml:lang="en"/>J Agric Food Chem. <year>2017</year>;<volume>65</volume>:<fpage>317</fpage>‐<lpage>326</lpage>.<pub-id pub-id-type="pmid">27991776</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0076">
<label>76</label>
<mixed-citation id="jcmm15028-cit-0076" publication-type="journal">
<string-name>
<surname>Hongwen Ma</surname>
<given-names>HWS</given-names>
</string-name>, <string-name>
<surname>Kolattukudy</surname>
<given-names>PE</given-names>
</string-name>. <article-title>Estrogen‐induced production of a peroxisome proliferator‐activated receptor (PPAR) ligand in a PPAR‐expressing tissue</article-title>. <source xml:lang="en"/>J Biol Chem. <year>1998</year>;<volume>273</volume>:<fpage>30131</fpage>‐<lpage>30138</lpage>.<pub-id pub-id-type="pmid">9804768</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0077">
<label>77</label>
<mixed-citation id="jcmm15028-cit-0077" publication-type="journal">
<string-name>
<surname>Borbath</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Horsmans</surname>
<given-names>Y</given-names>
</string-name>. <article-title>The role of PPARgamma in hepatocellular carcinoma</article-title>. <source xml:lang="en"/>PPAR Res. <year>2008</year>;<volume>2008</volume>:<fpage>209520</fpage>.<pub-id pub-id-type="pmid">18509497</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0078">
<label>78</label>
<mixed-citation id="jcmm15028-cit-0078" publication-type="journal">
<string-name>
<surname>Veliceasa</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Schulze‐Hoepfner</surname>
<given-names>FT</given-names>
</string-name>, <string-name>
<surname>Volpert</surname>
<given-names>OV</given-names>
</string-name>. <article-title>PPARgamma and agonists against cancer: rational design of complementation treatments</article-title>. <source xml:lang="en"/>PPAR Res. <year>2008</year>;<volume>2008</volume>:<fpage>945275</fpage>.<pub-id pub-id-type="pmid">19043603</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0079">
<label>79</label>
<mixed-citation id="jcmm15028-cit-0079" publication-type="journal">
<string-name>
<surname>Koga</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Sakisaka</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Harada</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone‐induced cell‐cycle arrest in human hepatoma cell lines</article-title>. <source xml:lang="en"/>Hepatology. <year>2001</year>;<volume>33</volume>:<fpage>1087</fpage>‐<lpage>1097</lpage>.<pub-id pub-id-type="pmid">11343236</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0080">
<label>80</label>
<mixed-citation id="jcmm15028-cit-0080" publication-type="journal">
<string-name>
<surname>Katherine</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Schaefer</surname>
<given-names>KW</given-names>
</string-name>, <string-name>
<surname>Takahashi</surname>
<given-names>H</given-names>
</string-name>, et al. <article-title>Peroxisome proliferator‐activated receptor; inhibition prevents adhesion to the extracellular matrix and induces anoikis in hepatocellular carcinoma cells</article-title>. <source xml:lang="en"/>Cancer Res. <year>2005</year>;<volume>65</volume>:<fpage>2251</fpage>‐<lpage>2259</lpage>.<pub-id pub-id-type="pmid">15781638</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0081">
<label>81</label>
<mixed-citation id="jcmm15028-cit-0081" publication-type="journal">
<string-name>
<surname>Lin</surname>
<given-names>YM</given-names>
</string-name>, <string-name>
<surname>Velmurugan</surname>
<given-names>BK</given-names>
</string-name>, <string-name>
<surname>Yeh</surname>
<given-names>YL</given-names>
</string-name>, et al. <article-title>Activation of estrogen receptors with E2 downregulates peroxisome proliferator‐activated receptor gamma in hepatocellular carcinoma</article-title>. <source xml:lang="en"/>Oncol Rep. <year>2013</year>;<volume>30</volume>:<fpage>3027</fpage>‐<lpage>3031</lpage>.<pub-id pub-id-type="pmid">24126791</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0082">
<label>82</label>
<mixed-citation id="jcmm15028-cit-0082" publication-type="journal">
<string-name>
<surname>Yu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Qiao</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Zimmermann</surname>
<given-names>L</given-names>
</string-name>, et al. <article-title>Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo</article-title>. <source xml:lang="en"/>Hepatology. <year>2006</year>;<volume>43</volume>:<fpage>134</fpage>‐<lpage>143</lpage>.<pub-id pub-id-type="pmid">16374840</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0083">
<label>83</label>
<mixed-citation id="jcmm15028-cit-0083" publication-type="journal">
<string-name>
<surname>Ming‐Yi Li</surname>
<given-names>HD</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>J‐M</given-names>
</string-name>, <string-name>
<surname>Dai</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Xiao‐Yu</surname>
<given-names>T</given-names>
</string-name>. <article-title>Peroxisome proliferator‐activated receptor gamma ligands inhibit cell growth and induce apoptosis in human liver cancer BEL‐7402 cells</article-title>. <source xml:lang="en"/>World J Gastroenterol. <year>2003</year>;<volume>9</volume>:<fpage>1683</fpage>‐<lpage>1688</lpage>.<pub-id pub-id-type="pmid">12918101</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0084">
<label>84</label>
<mixed-citation id="jcmm15028-cit-0084" publication-type="journal">
<string-name>
<surname>Toyoda</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Takagi</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Horiguchi</surname>
<given-names>N</given-names>
</string-name>, et al. <article-title>A ligand for peroxisome proliferator activated receptor gamma inhibits cell growth and induces apoptosis in human liver cancer cells</article-title>. <source xml:lang="en"/>Gut. <year>2002</year>;<volume>50</volume>:<fpage>563</fpage>‐<lpage>567</lpage>.<pub-id pub-id-type="pmid">11889080</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0085">
<label>85</label>
<mixed-citation id="jcmm15028-cit-0085" publication-type="journal">
<string-name>
<surname>Rumi</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Sato</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ishihara</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Peroxisome proliferator‐activated receptor gamma ligand‐induced growth inhibition of human hepatocellular carcinoma</article-title>. <source xml:lang="en"/>Br J Cancer. <year>2001</year>;<volume>84</volume>:<fpage>1640</fpage>‐<lpage>1647</lpage>.<pub-id pub-id-type="pmid">11401318</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0086">
<label>86</label>
<mixed-citation id="jcmm15028-cit-0086" publication-type="journal">
<string-name>
<surname>Koga</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Harada</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ohtsubo</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Troglitazone induces p27Kip1‐associated cell‐cycle arrest through down‐regulating Skp2 in human hepatoma cells</article-title>. <source xml:lang="en"/>Hepatology. <year>2003</year>;<volume>37</volume>:<fpage>1086</fpage>‐<lpage>1096</lpage>.<pub-id pub-id-type="pmid">12717389</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0087">
<label>87</label>
<mixed-citation id="jcmm15028-cit-0087" publication-type="journal">
<string-name>
<surname>Zhou</surname>
<given-names>YM</given-names>
</string-name>, <string-name>
<surname>Wen</surname>
<given-names>YH</given-names>
</string-name>, <string-name>
<surname>Kang</surname>
<given-names>XY</given-names>
</string-name>, <string-name>
<surname>Qian</surname>
<given-names>HH</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Yin</surname>
<given-names>ZF</given-names>
</string-name>. <article-title>Troglitazone, a peroxisome proliferator‐activated receptor gamma ligand, induces growth inhibition and apoptosis of HepG2 human liver cancer cells</article-title>. <source xml:lang="en"/>World J Gastroenterol. <year>2008</year>;<volume>14</volume>:<fpage>2168</fpage>‐<lpage>2173</lpage>.<pub-id pub-id-type="pmid">18407589</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0088">
<label>88</label>
<mixed-citation id="jcmm15028-cit-0088" publication-type="journal">
<string-name>
<surname>Wang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Quan</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Shen</surname>
<given-names>J</given-names>
</string-name>. <article-title>Avicularin ameliorates human hepatocellular carcinoma via the regulation of NFkappaB/COX2/PPARgamma activities</article-title>. <source xml:lang="en"/>Mol Med Rep. <year>2019</year>;<volume>19</volume>:<fpage>5417</fpage>‐<lpage>5423</lpage>.<pub-id pub-id-type="pmid">31059053</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0089">
<label>89</label>
<mixed-citation id="jcmm15028-cit-0089" publication-type="journal">
<string-name>
<surname>Han</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Gao</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ju</surname>
<given-names>P</given-names>
</string-name>, et al. <article-title>Hispidulin inhibits hepatocellular carcinoma growth and metastasis through AMPK and ERK signaling mediated activation of PPARgamma</article-title>. <source xml:lang="en"/>Biomed Pharmacother. <year>2018</year>;<volume>103</volume>:<fpage>272</fpage>‐<lpage>283</lpage>.<pub-id pub-id-type="pmid">29656183</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0090">
<label>90</label>
<mixed-citation id="jcmm15028-cit-0090" publication-type="journal">
<string-name>
<surname>Huang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Wei</surname>
<given-names>Y‐X</given-names>
</string-name>, <string-name>
<surname>Shen</surname>
<given-names>M‐C</given-names>
</string-name>, <string-name>
<surname>Tu</surname>
<given-names>Y‐H</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>C‐C</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>H‐C</given-names>
</string-name>. <article-title>Chrysin, abundant in morinda citrifolia fruit water–EtOAc extracts, combined with apigenin synergistically induced apoptosis and inhibited migration in human breast and liver cancer cells</article-title>. <source xml:lang="en"/>J Agric Food Chem. <year>2016</year>;<volume>64</volume>:<fpage>4235</fpage>‐<lpage>4245</lpage>.<pub-id pub-id-type="pmid">27137679</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0091">
<label>91</label>
<mixed-citation id="jcmm15028-cit-0091" publication-type="journal">
<string-name>
<surname>Vara</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Morell</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Rodriguez‐Henche</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Diaz‐Laviada</surname>
<given-names>I</given-names>
</string-name>. <article-title>Involvement of PPARgamma in the antitumoral action of cannabinoids on hepatocellular carcinoma</article-title>. <source xml:lang="en"/>Cell Death Dis. <year>2013</year>;<volume>4</volume>:<fpage>e618</fpage>.<pub-id pub-id-type="pmid">23640460</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0092">
<label>92</label>
<mixed-citation id="jcmm15028-cit-0092" publication-type="journal">
<string-name>
<surname>Zhang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>WE</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>J</given-names>
</string-name>. <article-title>Carotenoids inhibit proliferation and regulate expression of peroxisome proliferators‐activated receptor gamma (PPARgamma) in K562 cancer cells</article-title>. <source xml:lang="en"/>Arch Biochem Biophys. <year>2011</year>;<volume>512</volume>:<fpage>96</fpage>‐<lpage>106</lpage>.<pub-id pub-id-type="pmid">21620794</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0093">
<label>93</label>
<mixed-citation id="jcmm15028-cit-0093" publication-type="journal">
<string-name>
<surname>Zurlo</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Assante</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Moricca</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Colantuoni</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Lupo</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Cladosporol</surname>
<given-names>A</given-names>
</string-name>. <article-title>a new peroxisome proliferator‐activated receptor gamma (PPARgamma) ligand, inhibits colorectal cancer cells proliferation through beta‐catenin/TCF pathway inactivation</article-title>. <source xml:lang="en"/>Biochem Biophys Acta. <year>2014</year>;<volume>1840</volume>:<fpage>2361</fpage>‐<lpage>2372</lpage>.<pub-id pub-id-type="pmid">24735796</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0094">
<label>94</label>
<mixed-citation id="jcmm15028-cit-0094" publication-type="journal">
<string-name>
<surname>Kiskova</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kassayova</surname>
<given-names>M</given-names>
</string-name>. <article-title>Resveratrol action on lipid metabolism in cancer</article-title>. <source xml:lang="en"/>Int J Mol Sci. <year>2019</year>;<volume>20</volume>(<issue>11</issue>):<fpage>2704</fpage>.</mixed-citation>
</ref>
<ref id="jcmm15028-bib-0095">
<label>95</label>
<mixed-citation id="jcmm15028-cit-0095" publication-type="journal">
<string-name>
<surname>Ables</surname>
<given-names>GP</given-names>
</string-name>. <article-title>Update on ppargamma and nonalcoholic fatty liver disease</article-title>. <source xml:lang="en"/>PPAR Res. <year>2012</year>;<volume>2012</volume>:<fpage>912351</fpage>.<pub-id pub-id-type="pmid">22966224</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0096">
<label>96</label>
<mixed-citation id="jcmm15028-cit-0096" publication-type="journal">
<string-name>
<surname>Skat‐Rordam</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Hojland Ipsen</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Lykkesfeldt</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Tveden‐Nyborg</surname>
<given-names>P</given-names>
</string-name>. <article-title>A role of peroxisome proliferator‐activated receptor gamma in non‐alcoholic fatty liver disease</article-title>. <source xml:lang="en"/>Basic Clin Pharmacol Toxicol. <year>2019</year>;<volume>124</volume>:<fpage>528</fpage>‐<lpage>537</lpage>.<pub-id pub-id-type="pmid">30561132</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0097">
<label>97</label>
<mixed-citation id="jcmm15028-cit-0097" publication-type="journal">
<string-name>
<surname>Chinetti</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Fruchart</surname>
<given-names>J‐C</given-names>
</string-name>, <string-name>
<surname>Staels</surname>
<given-names>B</given-names>
</string-name>. <article-title>Peroxisome proliferator‐activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation</article-title>. <source xml:lang="en"/>Inflamm Res. <year>2000</year>;<volume>49</volume>:<fpage>497</fpage>‐<lpage>505</lpage>.<pub-id pub-id-type="pmid">11089900</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0098">
<label>98</label>
<mixed-citation id="jcmm15028-cit-0098" publication-type="journal">
<string-name>
<surname>Nan</surname>
<given-names>YM</given-names>
</string-name>, <string-name>
<surname>Fu</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>WJ</given-names>
</string-name>, et al. <article-title>Rosiglitazone prevents nutritional fibrosis and steatohepatitis in mice</article-title>. <source xml:lang="en"/>Scand J Gastroenterol. <year>2009</year>;<volume>44</volume>:<fpage>358</fpage>‐<lpage>365</lpage>.<pub-id pub-id-type="pmid">18991162</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0099">
<label>99</label>
<mixed-citation id="jcmm15028-cit-0099" publication-type="journal">
<string-name>
<surname>Camirand</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Marie</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Rabelo</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Silva</surname>
<given-names>JE</given-names>
</string-name>. <article-title>Thiazolidinediones stimulate uncoupling protein‐2 expression in cell lines representing white and brown adipose tissues and skeletal muscle</article-title>. <source xml:lang="en"/>Endocrinology. <year>1998</year>;<volume>139</volume>:<fpage>428</fpage>‐<lpage>431</lpage>.<pub-id pub-id-type="pmid">9421444</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0100">
<label>100</label>
<mixed-citation id="jcmm15028-cit-0100" publication-type="journal">
<string-name>
<surname>Wu</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Xie</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Morrison</surname>
<given-names>RF</given-names>
</string-name>, <string-name>
<surname>Bucher</surname>
<given-names>NL</given-names>
</string-name>, <string-name>
<surname>Farmer</surname>
<given-names>SR</given-names>
</string-name>. <article-title>PPARγ induces the insulin‐dependent glucose transporter GLUT4 in the absence of C/EBPα during the conversion of 3T3 fibroblasts into adipocytes</article-title>. <source xml:lang="en"/>J Clin Invest. <year>1998</year>;<volume>101</volume>:<fpage>22</fpage>‐<lpage>23</lpage>.<pub-id pub-id-type="pmid">9421462</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0101">
<label>101</label>
<mixed-citation id="jcmm15028-cit-0101" publication-type="journal">
<string-name>
<surname>Malloy</surname>
<given-names>VL</given-names>
</string-name>, <string-name>
<surname>Krajcik</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Bailey</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Hristopoulos</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Plummer</surname>
<given-names>JD</given-names>
</string-name>, <string-name>
<surname>Orentreich</surname>
<given-names>N</given-names>
</string-name>. <article-title>Methionine restriction decreases visceral fat mass and preserves insulin action in aging male Fischer 344 rats independent of energy restriction</article-title>. <source xml:lang="en"/>Aging Cell. <year>2006</year>;<volume>5</volume>:<fpage>305</fpage>‐<lpage>314</lpage>.<pub-id pub-id-type="pmid">16800846</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0102">
<label>102</label>
<mixed-citation id="jcmm15028-cit-0102" publication-type="journal">
<string-name>
<surname>Sun</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Tang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Tan</surname>
<given-names>X</given-names>
</string-name>, et al. <article-title>Activation of peroxisome proliferator‐activated receptor‐gamma by rosiglitazone improves lipid homeostasis at the adipose tissue‐liver axis in ethanol‐fed mice</article-title>. <source xml:lang="en"/>Am J Physiol Gastrointest Liver Physiol. <year>2012</year>;<volume>302</volume>:<fpage>G548</fpage>‐<lpage>G557</lpage>.<pub-id pub-id-type="pmid">22173916</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0103">
<label>103</label>
<mixed-citation id="jcmm15028-cit-0103" publication-type="journal">
<string-name>
<surname>Vidal‐Puig</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Jimenez‐Linan</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Lowell</surname>
<given-names>BB</given-names>
</string-name>, et al. <article-title>Regulation of PPAR gamma gene expression by nutrition and obesity in rodents</article-title>. <source xml:lang="en"/>J Clin Invest. <year>1996</year>;<volume>97</volume>:<fpage>2553</fpage>‐<lpage>2561</lpage>.<pub-id pub-id-type="pmid">8647948</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0104">
<label>104</label>
<mixed-citation id="jcmm15028-cit-0104" publication-type="journal">
<string-name>
<surname>Moran‐Salvador</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Lopez‐Parra</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Garcia‐Alonso</surname>
<given-names>V</given-names>
</string-name>, et al. <article-title>Role for PPARgamma in obesity‐induced hepatic steatosis as determined by hepatocyte‐ and macrophage‐specific conditional knockouts</article-title>. <source xml:lang="en"/>FASEB J. <year>2011</year>;<volume>25</volume>:<fpage>2538</fpage>‐<lpage>2550</lpage>.<pub-id pub-id-type="pmid">21507897</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0105">
<label>105</label>
<mixed-citation id="jcmm15028-cit-0105" publication-type="journal">
<string-name>
<surname>Uno</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Katagiri</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Yamada</surname>
<given-names>T</given-names>
</string-name>, et al. <article-title>Neuronal pathway from the liver modulates energy expenditure and systemic insulin sensitivity</article-title>. <source xml:lang="en"/>Science. <year>2006</year>;<volume>312</volume>:<fpage>1656</fpage>‐<lpage>1659</lpage>.<pub-id pub-id-type="pmid">16778057</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0106">
<label>106</label>
<mixed-citation id="jcmm15028-cit-0106" publication-type="journal">
<string-name>
<surname>Gavrilova</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Haluzik</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Matsusue</surname>
<given-names>K</given-names>
</string-name>, et al. <article-title>Liver peroxisome proliferator‐activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass</article-title>. <source xml:lang="en"/>J Biol Chem. <year>2003</year>;<volume>278</volume>:<fpage>34268</fpage>‐<lpage>34276</lpage>.<pub-id pub-id-type="pmid">12805374</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0107">
<label>107</label>
<mixed-citation id="jcmm15028-cit-0107" publication-type="journal">
<string-name>
<surname>Orsolya Mezei</surname>
<given-names>WJB</given-names>
</string-name>, <string-name>
<surname>Steger</surname>
<given-names>RW</given-names>
</string-name>, <string-name>
<surname>Peluso</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Winters</surname>
<given-names>TA</given-names>
</string-name>, <string-name>
<surname>Shay</surname>
<given-names>N</given-names>
</string-name>. <article-title>Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW 264.7 cells</article-title>. <source xml:lang="en"/>J Nutr. <year>2002</year>;<volume>133</volume>:<fpage>1238</fpage>‐<lpage>1243</lpage>.</mixed-citation>
</ref>
<ref id="jcmm15028-bib-0108">
<label>108</label>
<mixed-citation id="jcmm15028-cit-0108" publication-type="journal">
<string-name>
<surname>Andrade</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Paraiso</surname>
<given-names>AF</given-names>
</string-name>, <string-name>
<surname>de Oliveira</surname>
<given-names>MV</given-names>
</string-name>, et al. <article-title>Resveratrol attenuates hepatic steatosis in high‐fat fed mice by decreasing lipogenesis and inflammation</article-title>. <source xml:lang="en"/>Nutrition. <year>2014</year>;<volume>30</volume>:<fpage>915</fpage>‐<lpage>919</lpage>.<pub-id pub-id-type="pmid">24985011</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0109">
<label>109</label>
<mixed-citation id="jcmm15028-cit-0109" publication-type="journal">
<string-name>
<surname>Dominguez‐Avila</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Gonzalez‐Aguilar</surname>
<given-names>GA</given-names>
</string-name>, <string-name>
<surname>Alvarez‐Parrilla</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>de la Rosa</surname>
<given-names>LA</given-names>
</string-name>. <article-title>Modulation of expression and activity in response to polyphenolic compounds in high fat diets</article-title>. <source xml:lang="en"/>Int J Mol Sci. <year>2016</year>;<volume>17</volume>:<fpage>1002</fpage>.</mixed-citation>
</ref>
<ref id="jcmm15028-bib-0110">
<label>110</label>
<mixed-citation id="jcmm15028-cit-0110" publication-type="journal">
<string-name>
<surname>Feng</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Luo</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>Z</given-names>
</string-name>, et al. <article-title>Bavachinin, as a novel natural pan‐PPAR agonist, exhibits unique synergistic effects with synthetic PPAR‐gamma and PPAR‐alpha agonists on carbohydrate and lipid metabolism in db/db and diet‐induced obese mice</article-title>. <source xml:lang="en"/>Diabetologia. <year>2016</year>;<volume>59</volume>:<fpage>1276</fpage>‐<lpage>1286</lpage>.<pub-id pub-id-type="pmid">26983922</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0111">
<label>111</label>
<mixed-citation id="jcmm15028-cit-0111" publication-type="journal">
<string-name>
<surname>Barone</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Rizzo</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Tabbi</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Malaguarnera</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Frye</surname>
<given-names>RE</given-names>
</string-name>, <string-name>
<surname>Bastin</surname>
<given-names>J</given-names>
</string-name>. <article-title>Nuclear peroxisome proliferator‐activated receptors (PPARs) as therapeutic targets of resveratrol for autism spectrum disorder</article-title>. <source xml:lang="en"/>Int J Mol Sci. <year>2019</year>;<volume>20</volume>:<fpage>1878</fpage>.</mixed-citation>
</ref>
<ref id="jcmm15028-bib-0112">
<label>112</label>
<mixed-citation id="jcmm15028-cit-0112" publication-type="journal">
<string-name>
<surname>Serra</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Almeida</surname>
<given-names>LM</given-names>
</string-name>, <string-name>
<surname>Dinis</surname>
<given-names>TC</given-names>
</string-name>. <article-title>Anti‐inflammatory protection afforded by cyanidin‐3‐glucoside and resveratrol in human intestinal cells via Nrf2 and PPAR‐gamma: Comparison with 5‐aminosalicylic acid</article-title>. <source xml:lang="en"/>Chem Biol Interact. <year>2016</year>;<volume>260</volume>:<fpage>102</fpage>‐<lpage>109</lpage>.<pub-id pub-id-type="pmid">27818126</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0113">
<label>113</label>
<mixed-citation id="jcmm15028-cit-0113" publication-type="journal">
<string-name>
<surname>Regnault</surname>
<given-names>TR</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Chiu</surname>
<given-names>JS</given-names>
</string-name>, <string-name>
<surname>Gottheil</surname>
<given-names>SK</given-names>
</string-name>, <string-name>
<surname>Foran</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Yee</surname>
<given-names>SP</given-names>
</string-name>. <article-title>Peroxisome proliferator‐activated receptor ‐beta/delta, ‐gamma agonists and resveratrol modulate hypoxia induced changes in nuclear receptor activators of muscle oxidative metabolism</article-title>. <source xml:lang="en"/>PPAR Res. <year>2010</year>;<volume>2010</volume>:<fpage>129173</fpage>.<pub-id pub-id-type="pmid">21113404</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0114">
<label>114</label>
<mixed-citation id="jcmm15028-cit-0114" publication-type="journal">
<string-name>
<surname>Said</surname>
<given-names>RS</given-names>
</string-name>, <string-name>
<surname>El‐Demerdash</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Nada</surname>
<given-names>AS</given-names>
</string-name>, <string-name>
<surname>Kamal</surname>
<given-names>MM</given-names>
</string-name>. <article-title>Resveratrol inhibits inflammatory signaling implicated in ionizing radiation‐induced premature ovarian failure through antagonistic crosstalk between silencing information regulator 1 (SIRT1) and poly(ADP‐ribose) polymerase 1 (PARP‐1)</article-title>. <source xml:lang="en"/>Biochem Pharmacol. <year>2016</year>;<volume>103</volume>:<fpage>140</fpage>‐<lpage>150</lpage>.<pub-id pub-id-type="pmid">26827941</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0115">
<label>115</label>
<mixed-citation id="jcmm15028-cit-0115" publication-type="journal">
<string-name>
<surname>Jagtap</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Meganathan</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Wagh</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Winkler</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Hescheler</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Sachinidis</surname>
<given-names>A</given-names>
</string-name>. <article-title>Chemoprotective mechanism of the natural compounds, epigallocatechin‐3‐O‐gallate, quercetin and curcumin against cancer and cardiovascular diseases</article-title>. <source xml:lang="en"/>Curr Med Chem. <year>2009</year>;<volume>16</volume>:<fpage>1451</fpage>‐<lpage>1462</lpage>.<pub-id pub-id-type="pmid">19355899</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0116">
<label>116</label>
<mixed-citation id="jcmm15028-cit-0116" publication-type="journal">
<string-name>
<surname>Chen</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Zheng</surname>
<given-names>S</given-names>
</string-name>. <article-title>Curcumin inhibits connective tissue growth factor gene expression in activated hepatic stellate cells in vitro by blocking NF‐kappaB and ERK signalling</article-title>. <source xml:lang="en"/>Br J Pharmacol. <year>2008</year>;<volume>153</volume>:<fpage>557</fpage>‐<lpage>567</lpage>.<pub-id pub-id-type="pmid">17965732</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0117">
<label>117</label>
<mixed-citation id="jcmm15028-cit-0117" publication-type="journal">
<string-name>
<surname>Miao</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Liang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Bai</surname>
<given-names>M</given-names>
</string-name>. <article-title>The effect of different proportions of astragaloside and curcumin on DM model of mice</article-title>. <source xml:lang="en"/>Saudi Pharm J. <year>2017</year>;<volume>25</volume>:<fpage>477</fpage>‐<lpage>481</lpage>.<pub-id pub-id-type="pmid">28579878</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0118">
<label>118</label>
<mixed-citation id="jcmm15028-cit-0118" publication-type="journal">
<string-name>
<surname>Arzuman</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Beale</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Chan</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>JQ</given-names>
</string-name>, <string-name>
<surname>Huq</surname>
<given-names>F</given-names>
</string-name>. <article-title>Synergism from combinations of tris(benzimidazole) monochloroplatinum(II) chloride with capsaicin, quercetin, curcumin and cisplatin in human ovarian cancer cell lines</article-title>. <source xml:lang="en"/>Anticancer Res. <year>2014</year>;<volume>34</volume>:<fpage>5453</fpage>‐<lpage>5464</lpage>.<pub-id pub-id-type="pmid">25275041</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0119">
<label>119</label>
<mixed-citation id="jcmm15028-cit-0119" publication-type="journal">
<string-name>
<surname>Nishiyama</surname>
<given-names>TMT</given-names>
</string-name>, <string-name>
<surname>Kishida</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Tsukagawa</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Curcuminoids and sesquiterpenoids in turmeric (<italic>Curcuma longa</italic> L.) suppress an increase in blood glucose level in type 2 diabetic KK‐Ay mice</article-title>. <source xml:lang="en"/>J Agric Food Chem. <year>2005</year>;<volume>53</volume>:<fpage>959</fpage>‐<lpage>963</lpage>.<pub-id pub-id-type="pmid">15713005</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0120">
<label>120</label>
<mixed-citation id="jcmm15028-cit-0120" publication-type="journal">
<string-name>
<surname>Sakamoto</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Kanatsu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Toh</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Naka</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kondo</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Iida</surname>
<given-names>K</given-names>
</string-name>. <article-title>The dietary isoflavone daidzein reduces expression of pro‐inflammatory genes through PPARalpha/gamma and JNK pathways in adipocyte and macrophage co‐cultures</article-title>. <source xml:lang="en"/>PLoS ONE. <year>2016</year>;<volume>11</volume>:<elocation-id>e0149676</elocation-id>.<pub-id pub-id-type="pmid">26901838</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0121">
<label>121</label>
<mixed-citation id="jcmm15028-cit-0121" publication-type="journal">
<string-name>
<surname>Anandharajan</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Pathmanathan</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Shankernarayanan</surname>
<given-names>NP</given-names>
</string-name>, <string-name>
<surname>Vishwakarma</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Balakrishnan</surname>
<given-names>A</given-names>
</string-name>. <article-title>Upregulation of Glut‐4 and PPAR gamma by an isoflavone from <italic>Pterocarpus marsupium</italic> on L6 myotubes: a possible mechanism of action</article-title>. <source xml:lang="en"/>J Ethnopharmacol. <year>2005</year>;<volume>97</volume>:<fpage>253</fpage>‐<lpage>260</lpage>.<pub-id pub-id-type="pmid">15707762</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0122">
<label>122</label>
<mixed-citation id="jcmm15028-cit-0122" publication-type="journal">
<string-name>
<surname>Sun</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Bennett</surname>
<given-names>A</given-names>
</string-name>. <article-title>Cannabinoids: a new group of agonists of PPARs</article-title>. <source xml:lang="en"/>PPAR Res. <year>2007</year>;<volume>2007</volume>:<fpage>23513</fpage>.<pub-id pub-id-type="pmid">18288264</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0123">
<label>123</label>
<mixed-citation id="jcmm15028-cit-0123" publication-type="journal">
<string-name>
<surname>Campos</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Fogaca</surname>
<given-names>MV</given-names>
</string-name>, <string-name>
<surname>Sonego</surname>
<given-names>AB</given-names>
</string-name>, <string-name>
<surname>Guimaraes</surname>
<given-names>FS</given-names>
</string-name>. <article-title>Cannabidiol, neuroprotection and neuropsychiatric disorders</article-title>. <source xml:lang="en"/>Pharmacol Res. <year>2016</year>;<volume>112</volume>:<fpage>119</fpage>‐<lpage>127</lpage>.<pub-id pub-id-type="pmid">26845349</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0124">
<label>124</label>
<mixed-citation id="jcmm15028-cit-0124" publication-type="journal">
<string-name>
<surname>dos‐Santos‐Pereira</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>da‐Silva</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Guimarães</surname>
<given-names>FS</given-names>
</string-name>, <string-name>
<surname>Del‐Bel</surname>
<given-names>E</given-names>
</string-name>. <article-title>Co‐administration of cannabidiol and capsazepine reduces L‐DOPA‐induced dyskinesia in mice: possible mechanism of action</article-title>. <source xml:lang="en"/>Neurobiol Dis. <year>2016</year>;<volume>94</volume>:<fpage>179</fpage>‐<lpage>195</lpage>.<pub-id pub-id-type="pmid">27373843</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0125">
<label>125</label>
<mixed-citation id="jcmm15028-cit-0125" publication-type="journal">
<string-name>
<surname>Hegde</surname>
<given-names>VL</given-names>
</string-name>, <string-name>
<surname>Singh</surname>
<given-names>UP</given-names>
</string-name>, <string-name>
<surname>Nagarkatti</surname>
<given-names>PS</given-names>
</string-name>, <string-name>
<surname>Nagarkatti</surname>
<given-names>M</given-names>
</string-name>. <article-title>Critical role of mast cells and peroxisome proliferator‐activated receptor gamma in the induction of myeloid‐derived suppressor cells by marijuana cannabidiol in vivo</article-title>. <source xml:lang="en"/>J Immunol. <year>2015</year>;<volume>194</volume>:<fpage>5211</fpage>‐<lpage>5222</lpage>.<pub-id pub-id-type="pmid">25917103</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0126">
<label>126</label>
<mixed-citation id="jcmm15028-cit-0126" publication-type="journal">
<string-name>
<surname>Moldzio</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Pacher</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Krewenka</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>Effects of cannabinoids Delta(9)‐tetrahydrocannabinol, Delta(9)‐tetrahydrocannabinolic acid and cannabidiol in MPP+ affected murine mesencephalic cultures</article-title>. <source xml:lang="en"/>Phytomedicine. <year>2012</year>;<volume>19</volume>:<fpage>819</fpage>‐<lpage>824</lpage>.<pub-id pub-id-type="pmid">22571976</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0127">
<label>127</label>
<mixed-citation id="jcmm15028-cit-0127" publication-type="journal">
<string-name>
<surname>Ibeas Bih</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Nunn</surname>
<given-names>AV</given-names>
</string-name>, <string-name>
<surname>Bazelot</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Dallas</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Whalley</surname>
<given-names>BJ</given-names>
</string-name>. <article-title>Molecular targets of cannabidiol in neurological disorders</article-title>. <source xml:lang="en"/>Neurotherapeutics. <year>2015</year>;<volume>12</volume>:<fpage>699</fpage>‐<lpage>730</lpage>.<pub-id pub-id-type="pmid">26264914</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0128">
<label>128</label>
<mixed-citation id="jcmm15028-cit-0128" publication-type="journal">
<string-name>
<surname>Perez</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Cartarozzi</surname>
<given-names>LP</given-names>
</string-name>, <string-name>
<surname>Chiarotto</surname>
<given-names>GB</given-names>
</string-name>, <string-name>
<surname>Oliveira</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Guimaraes</surname>
<given-names>FS</given-names>
</string-name>, <string-name>
<surname>Oliveira</surname>
<given-names>ALR</given-names>
</string-name>. <article-title>Neuronal preservation and reactive gliosis attenuation following neonatal sciatic nerve axotomy by a fluorinated cannabidiol derivative</article-title>. <source xml:lang="en"/>Neuropharmacology. <year>2018</year>;<volume>140</volume>:<fpage>201</fpage>‐<lpage>208</lpage>.<pub-id pub-id-type="pmid">30096328</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0129">
<label>129</label>
<mixed-citation id="jcmm15028-cit-0129" publication-type="journal">
<string-name>
<surname>Onofri</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>de Meijer</surname>
<given-names>EPM</given-names>
</string-name>, <string-name>
<surname>Mandolino</surname>
<given-names>G</given-names>
</string-name>. <article-title>Sequence heterogeneity of cannabidiolic‐ and tetrahydrocannabinolic acid‐synthase in <italic>Cannabis sativa</italic> L. and its relationship with chemical phenotype</article-title>. <source xml:lang="en"/>Phytochemistry. <year>2015</year>;<volume>116</volume>:<fpage>57</fpage>‐<lpage>68</lpage>.<pub-id pub-id-type="pmid">25865737</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0130">
<label>130</label>
<mixed-citation id="jcmm15028-cit-0130" publication-type="journal">
<string-name>
<surname>Ebbert</surname>
<given-names>JO</given-names>
</string-name>, <string-name>
<surname>Scharf</surname>
<given-names>EL</given-names>
</string-name>, <string-name>
<surname>Hurt</surname>
<given-names>RT</given-names>
</string-name>. <article-title>Medical cannabis</article-title>. <source xml:lang="en"/>Mayo Clin Proc. <year>2018</year>;<volume>93</volume>:<fpage>1842</fpage>‐<lpage>1847</lpage>.<pub-id pub-id-type="pmid">30522595</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0131">
<label>131</label>
<mixed-citation id="jcmm15028-cit-0131" publication-type="journal">
<string-name>
<surname>Allsop</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Lintzeris</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Copeland</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Dunlop</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>McGregor</surname>
<given-names>IS</given-names>
</string-name>. <article-title>Cannabinoid replacement therapy (CRT): nabiximols (Sativex) as a novel treatment for cannabis withdrawal</article-title>. <source xml:lang="en"/>Clin Pharmacol Ther. <year>2015</year>;<volume>97</volume>:<fpage>571</fpage>‐<lpage>574</lpage>.<pub-id pub-id-type="pmid">25777582</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0132">
<label>132</label>
<mixed-citation id="jcmm15028-cit-0132" publication-type="journal">
<string-name>
<surname>Castelli</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Prosperini</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Pozzilli</surname>
<given-names>C</given-names>
</string-name>. <article-title>Balance worsening associated with nabiximols in multiple sclerosis</article-title>. <source xml:lang="en"/>Mult Scler. <year>2019</year>;<volume>25</volume>:<fpage>113</fpage>‐<lpage>117</lpage>.<pub-id pub-id-type="pmid">29533137</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0133">
<label>133</label>
<mixed-citation id="jcmm15028-cit-0133" publication-type="journal">
<string-name>
<surname>Riva</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Mora</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Sorarù</surname>
<given-names>G</given-names>
</string-name>, et al. <article-title>Safety and efficacy of nabiximols on spasticity symptoms in patients with motor neuron disease (CANALS): a multicentre, double‐blind, randomised, placebo‐controlled, phase 2 trial</article-title>. <source xml:lang="en"/>Lancet Neurol. <year>2019</year>;<volume>18</volume>:<fpage>155</fpage>‐<lpage>164</lpage>.<pub-id pub-id-type="pmid">30554828</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0134">
<label>134</label>
<mixed-citation id="jcmm15028-cit-0134" publication-type="journal">
<string-name>
<surname>Sorosina</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Clarelli</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Ferre</surname>
<given-names>L</given-names>
</string-name>, et al. <article-title>Clinical response to Nabiximols correlates with the downregulation of immune pathways in multiple sclerosis</article-title>. <source xml:lang="en"/>Eur J Neurol. <year>2018</year>;<volume>25</volume>:<fpage>934</fpage>‐e70.<pub-id pub-id-type="pmid">29528549</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0135">
<label>135</label>
<mixed-citation id="jcmm15028-cit-0135" publication-type="journal">
<string-name>
<surname>Kwok</surname>
<given-names>H‐H</given-names>
</string-name>, <string-name>
<surname>Guo</surname>
<given-names>G‐L</given-names>
</string-name>, <string-name>
<surname>Lau</surname>
<given-names>J‐C</given-names>
</string-name>, et al. <article-title>Stereoisomers ginsenosides‐20(S)‐Rg(3) and ‐20(R)‐Rg(3) differentially induce angiogenesis through peroxisome proliferator‐activated receptor‐gamma</article-title>. <source xml:lang="en"/>Biochem Pharmacol. <year>2012</year>;<volume>83</volume>:<fpage>893</fpage>‐<lpage>902</lpage>.<pub-id pub-id-type="pmid">22234331</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0136">
<label>136</label>
<mixed-citation id="jcmm15028-cit-0136" publication-type="journal">
<string-name>
<surname>Puhl</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Bernardes</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Silveira</surname>
<given-names>RL</given-names>
</string-name>, et al. <article-title>Mode of peroxisome proliferator‐activated receptor gamma activation by luteolin</article-title>. <source xml:lang="en"/>Mol Pharmacol. <year>2012</year>;<volume>81</volume>:<fpage>788</fpage>‐<lpage>799</lpage>.<pub-id pub-id-type="pmid">22391103</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0137">
<label>137</label>
<mixed-citation id="jcmm15028-cit-0137" publication-type="journal">
<string-name>
<surname>El‐Bassossy</surname>
<given-names>HM</given-names>
</string-name>, <string-name>
<surname>Abo‐Warda</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Fahmy</surname>
<given-names>A</given-names>
</string-name>. <article-title>Chrysin and luteolin alleviate vascular complications associated with insulin resistance mainly through PPAR‐gamma activation</article-title>. <source xml:lang="en"/>Am J Chin Med. <year>2014</year>;<volume>42</volume>:<fpage>1153</fpage>‐<lpage>1167</lpage>.<pub-id pub-id-type="pmid">25169908</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0138">
<label>138</label>
<mixed-citation id="jcmm15028-cit-0138" publication-type="journal">
<string-name>
<surname>Zhang</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Irwin</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>XN</given-names>
</string-name>, <string-name>
<surname>Sauriol</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Shi</surname>
<given-names>XW</given-names>
</string-name>. <article-title>PPARgamma agonist from <italic>Chromolaena odorata</italic>
</article-title>. <source xml:lang="en"/>J Nat Prod. <year>2012</year>;<volume>75</volume>:<fpage>2076</fpage>‐<lpage>2081</lpage>.<pub-id pub-id-type="pmid">23186307</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0139">
<label>139</label>
<mixed-citation id="jcmm15028-cit-0139" publication-type="journal">
<string-name>
<surname>Dat</surname>
<given-names>NT</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Hong</surname>
<given-names>YS</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>YH</given-names>
</string-name>, <string-name>
<surname>Minh</surname>
<given-names>CV</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>JJ</given-names>
</string-name>. <article-title>A peroxisome proliferator‐activated receptor‐gamma agonist and other constituents from <italic>Chromolaena odorata</italic>
</article-title>. <source xml:lang="en"/>Planta Med. <year>2009</year>;<volume>75</volume>:<fpage>803</fpage>‐<lpage>807</lpage>.<pub-id pub-id-type="pmid">19242902</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0140">
<label>140</label>
<mixed-citation id="jcmm15028-cit-0140" publication-type="journal">
<string-name>
<surname>Mahmoud</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Abdella</surname>
<given-names>EM</given-names>
</string-name>, <string-name>
<surname>El‐Derby</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Abdella</surname>
<given-names>EM</given-names>
</string-name>. <article-title>Protective effects of <italic>Turbinaria ornata</italic> and <italic>Padina pavonica</italic> against azoxymethane‐induced colon carcinogenesis through modulation of PPAR gamma, NF‐kappaB and oxidative stress</article-title>. <source xml:lang="en"/>Phytother Res. <year>2015</year>;<volume>29</volume>:<fpage>737</fpage>‐<lpage>748</lpage>.<pub-id pub-id-type="pmid">25676613</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0141">
<label>141</label>
<mixed-citation id="jcmm15028-cit-0141" publication-type="journal">
<string-name>
<surname>Jin</surname>
<given-names>YG</given-names>
</string-name>, <string-name>
<surname>Yuan</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>QQ</given-names>
</string-name>, et al. <article-title>Puerarin protects against cardiac fibrosis associated with the inhibition of TGF‐beta1/Smad2‐mediated endothelial‐to‐mesenchymal transition</article-title>. <source xml:lang="en"/>PPAR Res. <year>2017</year>;<volume>2017</volume>:<fpage>2647129</fpage>.<pub-id pub-id-type="pmid">28638404</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0142">
<label>142</label>
<mixed-citation id="jcmm15028-cit-0142" publication-type="journal">
<string-name>
<surname>Ma</surname>
<given-names>ZG</given-names>
</string-name>, <string-name>
<surname>Yuan</surname>
<given-names>YP</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>SC</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>SS</given-names>
</string-name>, <string-name>
<surname>Tang</surname>
<given-names>QZ</given-names>
</string-name>. <article-title>Piperine attenuates pathological cardiac fibrosis via PPAR‐gamma/AKT pathways</article-title>. <source xml:lang="en"/>EBioMedicine. <year>2017</year>;<volume>18</volume>:<fpage>179</fpage>‐<lpage>187</lpage>.<pub-id pub-id-type="pmid">28330809</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0143">
<label>143</label>
<mixed-citation id="jcmm15028-cit-0143" publication-type="journal">
<string-name>
<surname>Guan</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Qiao</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Lv</surname>
<given-names>Q</given-names>
</string-name>, et al. <article-title>Orally administered berberine ameliorates bleomycin‐induced pulmonary fibrosis in mice through promoting activation of PPAR‐gamma and subsequent expression of HGF in colons</article-title>. <source xml:lang="en"/>Toxicol Appl Pharmacol. <year>2018</year>;<volume>343</volume>:<fpage>1</fpage>‐<lpage>15</lpage>.<pub-id pub-id-type="pmid">29408570</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0144">
<label>144</label>
<mixed-citation id="jcmm15028-cit-0144" publication-type="journal">
<string-name>
<surname>Hsu</surname>
<given-names>WH</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>BH</given-names>
</string-name>, <string-name>
<surname>Pan</surname>
<given-names>TM</given-names>
</string-name>. <article-title>Monascin attenuates oxidative stress‐mediated lung inflammation via peroxisome proliferator‐activated receptor‐gamma (PPAR‐gamma) and nuclear factor‐erythroid 2 related factor 2 (Nrf‐2) modulation</article-title>. <source xml:lang="en"/>J Agric Food Chem. <year>2014</year>;<volume>62</volume>:<fpage>5337</fpage>‐<lpage>5344</lpage>.<pub-id pub-id-type="pmid">24865672</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0145">
<label>145</label>
<mixed-citation id="jcmm15028-cit-0145" publication-type="journal">
<string-name>
<surname>Lee</surname>
<given-names>BH</given-names>
</string-name>, <string-name>
<surname>Hsu</surname>
<given-names>WH</given-names>
</string-name>, <string-name>
<surname>Liao</surname>
<given-names>TH</given-names>
</string-name>, <string-name>
<surname>Pan</surname>
<given-names>TM</given-names>
</string-name>. <article-title>The Monascus metabolite monascin against TNF‐alpha‐induced insulin resistance via suppressing PPAR‐gamma phosphorylation in C2C12 myotubes</article-title>. <source xml:lang="en"/>Food Chem Toxicol. <year>2011</year>;<volume>49</volume>:<fpage>2609</fpage>‐<lpage>2617</lpage>.<pub-id pub-id-type="pmid">21777645</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0146">
<label>146</label>
<mixed-citation id="jcmm15028-cit-0146" publication-type="journal">
<string-name>
<surname>Hsu</surname>
<given-names>W‐H</given-names>
</string-name>, <string-name>
<surname>Pan</surname>
<given-names>T‐M</given-names>
</string-name>. <article-title>A novel PPARgamma agonist monascin's potential application in diabetes prevention</article-title>. <source xml:lang="en"/>Food Funct. <year>2014</year>;<volume>5</volume>:<fpage>1334</fpage>‐<lpage>1440</lpage>.<pub-id pub-id-type="pmid">24752777</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0147">
<label>147</label>
<mixed-citation id="jcmm15028-cit-0147" publication-type="journal">
<string-name>
<surname>Pelham</surname>
<given-names>CJ</given-names>
</string-name>, <string-name>
<surname>Ketsawatsomkron</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Groh</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Cullin‐3 regulates vascular smooth muscle function and arterial blood pressure via PPARgamma and RhoA/Rho‐kinase</article-title>. <source xml:lang="en"/>Cell Metab. <year>2012</year>;<volume>16</volume>:<fpage>462</fpage>‐<lpage>472</lpage>.<pub-id pub-id-type="pmid">23040068</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0148">
<label>148</label>
<mixed-citation id="jcmm15028-cit-0148" publication-type="journal">
<string-name>
<surname>Lee</surname>
<given-names>BH</given-names>
</string-name>, <string-name>
<surname>Hsu</surname>
<given-names>WH</given-names>
</string-name>, <string-name>
<surname>Chang</surname>
<given-names>YY</given-names>
</string-name>, <string-name>
<surname>Kuo</surname>
<given-names>HF</given-names>
</string-name>, <string-name>
<surname>Hsu</surname>
<given-names>YW</given-names>
</string-name>, <string-name>
<surname>Pan</surname>
<given-names>TM</given-names>
</string-name>. <article-title>Ankaflavin: a natural novel PPARgamma agonist upregulates Nrf2 to attenuate methylglyoxal‐induced diabetes in vivo</article-title>. <source xml:lang="en"/>Free Radic Biol Med. <year>2012</year>;<volume>53</volume>:<fpage>2008</fpage>‐<lpage>2016</lpage>.<pub-id pub-id-type="pmid">23022408</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0149">
<label>149</label>
<mixed-citation id="jcmm15028-cit-0149" publication-type="journal">
<string-name>
<surname>Inoue</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Tanabe</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Matsumoto</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Astaxanthin functions differently as a selective peroxisome proliferator‐activated receptor gamma modulator in adipocytes and macrophages</article-title>. <source xml:lang="en"/>Biochem Pharmacol. <year>2012</year>;<volume>84</volume>:<fpage>692</fpage>‐<lpage>700</lpage>.<pub-id pub-id-type="pmid">22732454</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0150">
<label>150</label>
<mixed-citation id="jcmm15028-cit-0150" publication-type="journal">
<string-name>
<surname>Qiu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>X</given-names>
</string-name>. <article-title>Biochanin A ameliorates the cytokine secretion profile of lipopolysaccharide‐stimulated macrophages by a PPARgamma‐dependent pathway</article-title>. <source xml:lang="en"/>Mol Med Rep. <year>2012</year>;<volume>5</volume>:<fpage>217</fpage>‐<lpage>222</lpage>.<pub-id pub-id-type="pmid">21946955</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0151">
<label>151</label>
<mixed-citation id="jcmm15028-cit-0151" publication-type="journal">
<string-name>
<surname>Liu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Danhong inhibits oxidized low‐density lipoprotein‐induced immune maturation of dentritic cells via a peroxisome proliferator activated receptor gamma‐mediated pathway</article-title>. <source xml:lang="en"/>J Pharmacol Sci. <year>2012</year>;<volume>119</volume>:<fpage>1</fpage>‐<lpage>9</lpage>.<pub-id pub-id-type="pmid">22739234</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0152">
<label>152</label>
<mixed-citation id="jcmm15028-cit-0152" publication-type="journal">
<string-name>
<surname>Hurtado</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Ballesteros</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Cuartero</surname>
<given-names>MI</given-names>
</string-name>, et al. <article-title>Daidzein has neuroprotective effects through ligand‐binding‐independent PPARgamma activation</article-title>. <source xml:lang="en"/>Neurochem Int. <year>2012</year>;<volume>61</volume>:<fpage>119</fpage>‐<lpage>127</lpage>.<pub-id pub-id-type="pmid">22521773</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0153">
<label>153</label>
<mixed-citation id="jcmm15028-cit-0153" publication-type="journal">
<string-name>
<surname>Liu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Mao</surname>
<given-names>G</given-names>
</string-name>, et al. <article-title>Epigallocatechin‐3‐O‐gallate, a green tea polyphenol, induces expression of pim‐1 kinase via PPARgamma in human vascular endothelial cells</article-title>. <source xml:lang="en"/>Cardiovasc Toxicol. <year>2013</year>;<volume>13</volume>:<fpage>391</fpage>‐<lpage>395</lpage>.<pub-id pub-id-type="pmid">23990052</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0154">
<label>154</label>
<mixed-citation id="jcmm15028-cit-0154" publication-type="journal">
<string-name>
<surname>Kim</surname>
<given-names>SH</given-names>
</string-name>, <string-name>
<surname>Hong</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>YC</given-names>
</string-name>. <article-title>Ursolic acid, a potential PPARgamma agonist, suppresses ovalbumin‐induced airway inflammation and Penh by down‐regulating IL‐5, IL‐13, and IL‐17 in a mouse model of allergic asthma</article-title>. <source xml:lang="en"/>Eur J Pharmacol. <year>2013</year>;<volume>701</volume>:<fpage>131</fpage>‐<lpage>143</lpage>.<pub-id pub-id-type="pmid">23201068</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0155">
<label>155</label>
<mixed-citation id="jcmm15028-cit-0155" publication-type="journal">
<string-name>
<surname>Lee</surname>
<given-names>BH</given-names>
</string-name>, <string-name>
<surname>Hsu</surname>
<given-names>WH</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Chang</surname>
<given-names>YY</given-names>
</string-name>, <string-name>
<surname>Hsu</surname>
<given-names>YW</given-names>
</string-name>, <string-name>
<surname>Pan</surname>
<given-names>TM</given-names>
</string-name>. <article-title>Monascin improves diabetes and dyslipidemia by regulating PPARgamma and inhibiting lipogenesis in fructose‐rich diet‐induced C57BL/6 mice</article-title>. <source xml:lang="en"/>Food Funct. <year>2013</year>;<volume>4</volume>:<fpage>950</fpage>‐<lpage>959</lpage>.<pub-id pub-id-type="pmid">23673903</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0156">
<label>156</label>
<mixed-citation id="jcmm15028-cit-0156" publication-type="journal">
<string-name>
<surname>Rani</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Bharti</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Bhatia</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Inhibition of TGF‐beta by a novel PPAR‐gamma agonist, chrysin, salvages beta‐receptor stimulated myocardial injury in rats through MAPKs‐dependent mechanism</article-title>. <source xml:lang="en"/>Nutr Metab (Lond). <year>2015</year>;<volume>12</volume>:<fpage>11</fpage>.<pub-id pub-id-type="pmid">25774203</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0157">
<label>157</label>
<mixed-citation id="jcmm15028-cit-0157" publication-type="journal">
<string-name>
<surname>Jin</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Peng</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Rhizoma dioscoreae nipponicae polysaccharides protect HUVECs from H<sub>2</sub>O<sub>2</sub>‐induced injury by regulating PPARgamma factor and the NADPH oxidase/ROS‐NF‐kappaB signal pathway</article-title>. <source xml:lang="en"/>Toxicol Lett. <year>2015</year>;<volume>232</volume>:<fpage>149</fpage>‐<lpage>158</lpage>.<pub-id pub-id-type="pmid">25305479</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0158">
<label>158</label>
<mixed-citation id="jcmm15028-cit-0158" publication-type="journal">
<string-name>
<surname>Kim</surname>
<given-names>TK</given-names>
</string-name>, <string-name>
<surname>Park</surname>
<given-names>KS</given-names>
</string-name>. <article-title>Inhibitory effects of harpagoside on TNF‐alpha‐induced pro‐inflammatory adipokine expression through PPAR‐gamma activation in 3T3‐L1 adipocytes</article-title>. <source xml:lang="en"/>Cytokine. <year>2015</year>;<volume>76</volume>:<fpage>368</fpage>‐<lpage>374</lpage>.<pub-id pub-id-type="pmid">26049170</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0159">
<label>159</label>
<mixed-citation id="jcmm15028-cit-0159" publication-type="journal">
<string-name>
<surname>Li</surname>
<given-names>QY</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Yan</surname>
<given-names>MM</given-names>
</string-name>, <string-name>
<surname>Shi</surname>
<given-names>XJ</given-names>
</string-name>, <string-name>
<surname>Zhong</surname>
<given-names>MK</given-names>
</string-name>. <article-title>Tectorigenin regulates adipogenic differentiation and adipocytokines secretion via PPARgamma and IKK/NF‐kappaB signaling</article-title>. <source xml:lang="en"/>Pharm Biol. <year>2015</year>;<volume>53</volume>:<fpage>1567</fpage>‐<lpage>1575</lpage>.<pub-id pub-id-type="pmid">25856699</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0160">
<label>160</label>
<mixed-citation id="jcmm15028-cit-0160" publication-type="journal">
<string-name>
<surname>Rani</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Bharti</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Bhatia</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Nag</surname>
<given-names>TC</given-names>
</string-name>, <string-name>
<surname>Ray</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Arya</surname>
<given-names>DS</given-names>
</string-name>. <article-title>Chrysin, a PPAR‐gamma agonist improves myocardial injury in diabetic rats through inhibiting AGE‐RAGE mediated oxidative stress and inflammation</article-title>. <source xml:lang="en"/>Chem Biol Interact. <year>2016</year>;<volume>250</volume>:<fpage>59</fpage>‐<lpage>67</lpage>.<pub-id pub-id-type="pmid">26972669</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0161">
<label>161</label>
<mixed-citation id="jcmm15028-cit-0161" publication-type="journal">
<string-name>
<surname>Ge</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Miao</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>XY</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>JY</given-names>
</string-name>. <article-title>Huangkui capsule, an extract from <italic>Abelmoschus manihot</italic> (L.) medic, improves diabetic nephropathy via activating peroxisome proliferator‐activated receptor (PPAR)‐alpha/gamma and attenuating endoplasmic reticulum stress in rats</article-title>. <source xml:lang="en"/>J Ethnopharmacol. <year>2016</year>;<volume>189</volume>:<fpage>238</fpage>‐<lpage>249</lpage>.<pub-id pub-id-type="pmid">27224243</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0162">
<label>162</label>
<mixed-citation id="jcmm15028-cit-0162" publication-type="journal">
<string-name>
<surname>Lin</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>LM</given-names>
</string-name>, <string-name>
<surname>Pan</surname>
<given-names>XD</given-names>
</string-name>, et al. <article-title>Tripchlorolide attenuates beta‐amyloid generation via suppressing PPARgamma‐regulated BACE1 activity in N2a/APP695 cells</article-title>. <source xml:lang="en"/>Mol Neurobiol. <year>2016</year>;<volume>53</volume>:<fpage>6397</fpage>‐<lpage>6406</lpage>.<pub-id pub-id-type="pmid">26582466</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0163">
<label>163</label>
<mixed-citation id="jcmm15028-cit-0163" publication-type="journal">
<string-name>
<surname>Jeon</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>DH</given-names>
</string-name>, <string-name>
<surname>Nho</surname>
<given-names>YH</given-names>
</string-name>, <string-name>
<surname>Park</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>SN</given-names>
</string-name>, <string-name>
<surname>Choi</surname>
<given-names>EH</given-names>
</string-name>. <article-title>A mixture of extracts of <italic>Kochia scoparia</italic> and <italic>Rosa multiflora</italic> with PPAR alpha/gamma dual agonistic effects prevents photoaging in hairless mice</article-title>. <source xml:lang="en"/>Int J Mol Sci. <year>2016</year>;<volume>17</volume>:<fpage>1919</fpage>.</mixed-citation>
</ref>
<ref id="jcmm15028-bib-0164">
<label>164</label>
<mixed-citation id="jcmm15028-cit-0164" publication-type="journal">
<string-name>
<surname>Zhang</surname>
<given-names>ZX</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>YB</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>RP</given-names>
</string-name>. <article-title>Epigallocatechin gallate attenuates beta‐amyloid generation and oxidative stress involvement of PPARgamma in N2a/APP695 cells</article-title>. <source xml:lang="en"/>Neurochem Res. <year>2017</year>;<volume>42</volume>:<fpage>468</fpage>‐<lpage>480</lpage>.<pub-id pub-id-type="pmid">27889855</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0165">
<label>165</label>
<mixed-citation id="jcmm15028-cit-0165" publication-type="journal">
<string-name>
<surname>Tsujino</surname>
<given-names>Y</given-names>
</string-name>. <article-title>A new agonist for peroxisome proliferation‐activated receptor gamma (PPARgamma), Fraglide‐1 from Zhenjiang fragrant vinegar: screening and characterization based on cell culture experiments</article-title>. <source xml:lang="en"/>J Oleo Sci. <year>2017</year>;<volume>66</volume>:<fpage>615</fpage>‐<lpage>622</lpage>.<pub-id pub-id-type="pmid">28515383</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0166">
<label>166</label>
<mixed-citation id="jcmm15028-cit-0166" publication-type="journal">
<string-name>
<surname>Xu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wei</surname>
<given-names>Z</given-names>
</string-name>, et al. <article-title>Madecassic acid, the contributor to the anti‐colitis effect of madecassoside, enhances the shift of Th17 toward Treg cells via the PPARgamma/AMPK/ACC1 pathway</article-title>. <source xml:lang="en"/>Cell Death Dis. <year>2017</year>;<volume>8</volume>:<elocation-id>e2723</elocation-id>.<pub-id pub-id-type="pmid">28358365</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0167">
<label>167</label>
<mixed-citation id="jcmm15028-cit-0167" publication-type="journal">
<string-name>
<surname>Ke</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Ke</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Wan</surname>
<given-names>X</given-names>
</string-name>, et al. <article-title>Astragalus polysaccharides attenuates TNF‐alpha‐induced insulin resistance via suppression of miR‐721 and activation of PPAR‐gamma and PI3K/AKT in 3T3‐L1 adipocytes</article-title>. <source xml:lang="en"/>Am J Transl Res. <year>2017</year>;<volume>9</volume>:<fpage>2195</fpage>‐<lpage>2206</lpage>.<pub-id pub-id-type="pmid">28559971</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0168">
<label>168</label>
<mixed-citation id="jcmm15028-cit-0168" publication-type="journal">
<string-name>
<surname>Xu</surname>
<given-names>LJ</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>MH</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>CY</given-names>
</string-name>, et al. <article-title>Isoprenylated flavonoids from <italic>Morus nigra </italic>and their PPAR gamma agonistic activities</article-title>. <source xml:lang="en"/>Fitoterapia. <year>2018</year>;<volume>127</volume>:<fpage>109</fpage>‐<lpage>114</lpage>.<pub-id pub-id-type="pmid">29427594</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0169">
<label>169</label>
<mixed-citation id="jcmm15028-cit-0169" publication-type="journal">
<string-name>
<surname>Bhat</surname>
<given-names>OM</given-names>
</string-name>, <string-name>
<surname>Kumar</surname>
<given-names>PU</given-names>
</string-name>, <string-name>
<surname>Rao</surname>
<given-names>KR</given-names>
</string-name>, <string-name>
<surname>Ahmad</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Dhawan</surname>
<given-names>V</given-names>
</string-name>. <article-title>Terminalia arjuna prevents interleukin‐18‐induced atherosclerosis via modulation of NF‐kappaB/PPAR‐gamma‐mediated pathway in Apo E‐/‐ mice</article-title>. <source xml:lang="en"/>Inflammopharmacology. <year>2018</year>;<volume>26</volume>:<fpage>583</fpage>‐<lpage>598</lpage>.<pub-id pub-id-type="pmid">28547701</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0170">
<label>170</label>
<mixed-citation id="jcmm15028-cit-0170" publication-type="journal">
<string-name>
<surname>Kong</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Luo</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>N</given-names>
</string-name>, et al. <article-title>Portulaca extract attenuates development of dextran sulfate sodium induced colitis in mice through activation of PPARgamma</article-title>. <source xml:lang="en"/>PPAR Res. <year>2018</year>;<volume>2018</volume>:<fpage>6079101</fpage>.<pub-id pub-id-type="pmid">29483924</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0171">
<label>171</label>
<mixed-citation id="jcmm15028-cit-0171" publication-type="journal">
<string-name>
<surname>Xu</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Zan</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>HY</given-names>
</string-name>, et al. <article-title>Betulin inhibits lipopolysaccharide/D‐galactosamine‐induced acute liver injury in mice through activating PPAR‐gamma</article-title>. <source xml:lang="en"/>Biomed Pharmacother. <year>2018</year>;<volume>106</volume>:<fpage>941</fpage>‐<lpage>945</lpage>.<pub-id pub-id-type="pmid">30119266</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0172">
<label>172</label>
<mixed-citation id="jcmm15028-cit-0172" publication-type="journal">
<string-name>
<surname>Cui</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Kandhare</surname>
<given-names>AD</given-names>
</string-name>, <string-name>
<surname>Mukherjee‐Kandhare</surname>
<given-names>AA</given-names>
</string-name>, <string-name>
<surname>Bodhankar</surname>
<given-names>SL</given-names>
</string-name>. <article-title>Neuroprotective effect of naringin, a flavone glycoside in quinolinic acid‐induced neurotoxicity: possible role of PPAR‐gamma, Bax/Bcl‐2, and caspase‐3</article-title>. <source xml:lang="en"/>Food Chem Toxicol. <year>2018</year>;<volume>121</volume>:<fpage>95</fpage>‐<lpage>108</lpage>.<pub-id pub-id-type="pmid">30130594</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0173">
<label>173</label>
<mixed-citation id="jcmm15028-cit-0173" publication-type="journal">
<string-name>
<surname>Youssef</surname>
<given-names>DA</given-names>
</string-name>, <string-name>
<surname>El‐Fayoumi</surname>
<given-names>HM</given-names>
</string-name>, <string-name>
<surname>Mahmoud</surname>
<given-names>MF</given-names>
</string-name>. <article-title>Beta‐caryophyllene protects against diet‐induced dyslipidemia and vascular inflammation in rats: Involvement of CB2 and PPAR‐gamma receptors</article-title>. <source xml:lang="en"/>Chem Biol Interact. <year>2019</year>;<volume>297</volume>:<fpage>16</fpage>‐<lpage>24</lpage>.<pub-id pub-id-type="pmid">30343038</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0174">
<label>174</label>
<mixed-citation id="jcmm15028-cit-0174" publication-type="journal">
<string-name>
<surname>Badawy</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>El‐Naga</surname>
<given-names>RN</given-names>
</string-name>, <string-name>
<surname>Gad</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Tadros</surname>
<given-names>MG</given-names>
</string-name>, <string-name>
<surname>Fawzy</surname>
<given-names>HM</given-names>
</string-name>. <article-title>Wogonin pre‐treatment attenuates cisplatin‐induced nephrotoxicity in rats: Impact on PPAR‐gamma, inflammation, apoptosis and Wnt/beta‐catenin pathway</article-title>. <source xml:lang="en"/>Chem Biol Interact. <year>2019</year>;<volume>308</volume>:<fpage>137</fpage>‐<lpage>146</lpage>.<pub-id pub-id-type="pmid">31103702</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0175">
<label>175</label>
<mixed-citation id="jcmm15028-cit-0175" publication-type="journal">
<string-name>
<surname>Meng</surname>
<given-names>HW</given-names>
</string-name>, <string-name>
<surname>You</surname>
<given-names>HM</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>Y</given-names>
</string-name>, et al. <article-title>4‐Methylcoumarin‐[5,6‐g]‐hesperetin attenuates inflammatory responses in alcoholic hepatitis through PPAR‐gamma activation</article-title>. <source xml:lang="en"/>Toxicology. <year>2019</year>;<volume>421</volume>:<fpage>9</fpage>‐<lpage>21</lpage>.<pub-id pub-id-type="pmid">30951781</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0176">
<label>176</label>
<mixed-citation id="jcmm15028-cit-0176" publication-type="journal">
<string-name>
<surname>Wakabayashi</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Hayashi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Matsui</surname>
<given-names>Y</given-names>
</string-name>, et al. <article-title>Pharmacology and in vitro profiling of a novel peroxisome proliferator‐activated receptor gamma ligand, Cerco‐A</article-title>. <source xml:lang="en"/>Biol Pharm Bull. <year>2011</year>;<volume>34</volume>:<fpage>1094</fpage>‐<lpage>1104</lpage>.<pub-id pub-id-type="pmid">21720019</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0177">
<label>177</label>
<mixed-citation id="jcmm15028-cit-0177" publication-type="journal">
<string-name>
<surname>Kwon</surname>
<given-names>DY</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>DS</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>HJ</given-names>
</string-name>, <string-name>
<surname>Park</surname>
<given-names>S</given-names>
</string-name>. <article-title>The lignan‐rich fractions of Fructus Schisandrae improve insulin sensitivity via the PPAR‐gamma pathways in in vitro and in vivo studies</article-title>. <source xml:lang="en"/>J Ethnopharmacol. <year>2011</year>;<volume>135</volume>:<fpage>455</fpage>‐<lpage>462</lpage>.<pub-id pub-id-type="pmid">21440615</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0178">
<label>178</label>
<mixed-citation id="jcmm15028-cit-0178" publication-type="journal">
<string-name>
<surname>Xu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Lai</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>Y</given-names>
</string-name>, et al. <article-title>Mycophenolic acid induces ATP‐binding cassette transporter A1 (ABCA1) expression through the PPARgamma‐LXRalpha‐ABCA1 pathway</article-title>. <source xml:lang="en"/>Biochem Biophys Res Commun. <year>2011</year>;<volume>414</volume>:<fpage>779</fpage>‐<lpage>782</lpage>.<pub-id pub-id-type="pmid">22005457</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0179">
<label>179</label>
<mixed-citation id="jcmm15028-cit-0179" publication-type="journal">
<string-name>
<surname>Weidner</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Wowro</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Freiwald</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Amorfrutin B is an efficient natural peroxisome proliferator‐activated receptor gamma (PPARgamma) agonist with potent glucose‐lowering properties</article-title>. <source xml:lang="en"/>Diabetologia. <year>2013</year>;<volume>56</volume>:<fpage>1802</fpage>‐<lpage>1812</lpage>.<pub-id pub-id-type="pmid">23680913</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0180">
<label>180</label>
<mixed-citation id="jcmm15028-cit-0180" publication-type="journal">
<string-name>
<surname>Atanasov</surname>
<given-names>AG</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>JN</given-names>
</string-name>, <string-name>
<surname>Gu</surname>
<given-names>SP</given-names>
</string-name>, et al. <article-title>Honokiol: a non‐adipogenic PPARgamma agonist from nature</article-title>. <source xml:lang="en"/>Biochem Biophys Acta. <year>2013</year>;<volume>1830</volume>:<fpage>4813</fpage>‐<lpage>4819</lpage>.<pub-id pub-id-type="pmid">23811337</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0181">
<label>181</label>
<mixed-citation id="jcmm15028-cit-0181" publication-type="journal">
<string-name>
<surname>Shyni</surname>
<given-names>GL</given-names>
</string-name>, <string-name>
<surname>Kavitha</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Indu</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Chebulagic acid from <italic>Terminalia chebula</italic> enhances insulin mediated glucose uptake in 3T3‐L1 adipocytes via PPARgamma signaling pathway</article-title>. <source xml:lang="en"/>BioFactors. <year>2014</year>;<volume>40</volume>:<fpage>646</fpage>‐<lpage>657</lpage>.<pub-id pub-id-type="pmid">25529897</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0182">
<label>182</label>
<mixed-citation id="jcmm15028-cit-0182" publication-type="journal">
<string-name>
<surname>Beekmann</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Rubió</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>de Haan</surname>
<given-names>LH</given-names>
</string-name>. <article-title>The effect of quercetin and kaempferol aglycones and glucuronides on peroxisome proliferator‐activated receptor‐gamma (PPAR‐gamma)</article-title>. <source xml:lang="en"/>Food Funct. <year>2015</year>;<volume>6</volume>:<fpage>1098</fpage>‐<lpage>1107</lpage>.<pub-id pub-id-type="pmid">25765892</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0183">
<label>183</label>
<mixed-citation id="jcmm15028-cit-0183" publication-type="journal">
<string-name>
<surname>Han</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>MH</given-names>
</string-name>, <string-name>
<surname>Choi</surname>
<given-names>YY</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Hong</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>WM</given-names>
</string-name>. <article-title>Effects of <italic>Lonicera japonica</italic> Thunb. on type 2 diabetes via PPAR‐gamma activation in rats</article-title>. <source xml:lang="en"/>Phytotherapy Res. <year>2015</year>;<volume>29</volume>:<fpage>1616</fpage>‐<lpage>1621</lpage>.</mixed-citation>
</ref>
<ref id="jcmm15028-bib-0184">
<label>184</label>
<mixed-citation id="jcmm15028-cit-0184" publication-type="journal">
<string-name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Gu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Cai</surname>
<given-names>W</given-names>
</string-name>, et al. <article-title>Dietary component isorhamnetin is a PPARgamma antagonist and ameliorates metabolic disorders induced by diet or leptin deficiency</article-title>. <source xml:lang="en"/>Sci Rep. <year>2016</year>;<volume>6</volume>:<fpage>19288</fpage>.<pub-id pub-id-type="pmid">26775807</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0185">
<label>185</label>
<mixed-citation id="jcmm15028-cit-0185" publication-type="journal">
<string-name>
<surname>Montanari</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Capelli</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Tava</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Screening of saponins and sapogenins from Medicago species as potential PPARgamma agonists and X‐ray structure of the complex PPARgamma/caulophyllogenin</article-title>. <source xml:lang="en"/>Sci Rep. <year>2016</year>;<volume>6</volume>:<fpage>27658</fpage>.<pub-id pub-id-type="pmid">27283034</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0186">
<label>186</label>
<mixed-citation id="jcmm15028-cit-0186" publication-type="journal">
<string-name>
<surname>Kunasegaran</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Mustafa</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Murugan</surname>
<given-names>DD</given-names>
</string-name>, <string-name>
<surname>Achike</surname>
<given-names>FI</given-names>
</string-name>. <article-title>The bioflavonoid quercetin synergises with PPAR‐gamma agonist pioglitazone in reducing angiotensin‐II contractile effect in fructose‐streptozotocin induced diabetic rats</article-title>. <source xml:lang="en"/>Biochimie. <year>2016</year>;<volume>125</volume>:<fpage>131</fpage>‐<lpage>139</lpage>.<pub-id pub-id-type="pmid">27012965</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0187">
<label>187</label>
<mixed-citation id="jcmm15028-cit-0187" publication-type="journal">
<string-name>
<surname>Qi</surname>
<given-names>ZG</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Zhong</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Xie</surname>
<given-names>ML</given-names>
</string-name>. <article-title>Osthole improves glucose and lipid metabolism via modulation of PPARalpha/gamma‐mediated target gene expression in liver, adipose tissue, and skeletal muscle in fatty liver rats</article-title>. <source xml:lang="en"/>Pharm Biol. <year>2016</year>;<volume>54</volume>:<fpage>882</fpage>‐<lpage>888</lpage>.<pub-id pub-id-type="pmid">26455539</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0188">
<label>188</label>
<mixed-citation id="jcmm15028-cit-0188" publication-type="journal">
<string-name>
<surname>Wang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>JP</given-names>
</string-name>, et al. <article-title>Astragaloside IV, a natural PPARgamma agonist, reduces abeta production in Alzheimer's disease through inhibition of BACE1</article-title>. <source xml:lang="en"/>Mol Neurobiol. <year>2017</year>;<volume>54</volume>:<fpage>2939</fpage>‐<lpage>2949</lpage>.<pub-id pub-id-type="pmid">27023226</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0189">
<label>189</label>
<mixed-citation id="jcmm15028-cit-0189" publication-type="journal">
<string-name>
<surname>Nadal</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Del Rio</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Casano</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Tetrahydrocannabinolic acid is a potent PPARgamma agonist with neuroprotective activity</article-title>. <source xml:lang="en"/>Br J Pharmacol. <year>2017</year>;<volume>174</volume>:<fpage>4263</fpage>‐<lpage>4276</lpage>.<pub-id pub-id-type="pmid">28853159</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0190">
<label>190</label>
<mixed-citation id="jcmm15028-cit-0190" publication-type="journal">
<string-name>
<surname>Chen</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Wan</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Song</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Qian</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Gu</surname>
<given-names>S</given-names>
</string-name>. <article-title>Rational screening of peroxisome proliferator‐activated receptor‐gamma agonists from natural products: potential therapeutics for heart failure</article-title>. <source xml:lang="en"/>Pharm Biol. <year>2017</year>;<volume>55</volume>:<fpage>503</fpage>‐<lpage>509</lpage>.<pub-id pub-id-type="pmid">27937122</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0191">
<label>191</label>
<mixed-citation id="jcmm15028-cit-0191" publication-type="journal">
<string-name>
<surname>Kim</surname>
<given-names>MH</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>EJ</given-names>
</string-name>, <string-name>
<surname>Choi</surname>
<given-names>YY</given-names>
</string-name>, <string-name>
<surname>Hong</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>WM</given-names>
</string-name>. <article-title>Lycium chinense improves post‐menopausal obesity via regulation of PPAR‐gamma and estrogen receptor‐alpha/beta expressions</article-title>. <source xml:lang="en"/>Am J Chin Med. <year>2017</year>;<volume>45</volume>:<fpage>269</fpage>‐<lpage>282</lpage>.<pub-id pub-id-type="pmid">28231739</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0192">
<label>192</label>
<mixed-citation id="jcmm15028-cit-0192" publication-type="journal">
<string-name>
<surname>Peng</surname>
<given-names>SG</given-names>
</string-name>, <string-name>
<surname>Pang</surname>
<given-names>YL</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Kang</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>MX</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Z</given-names>
</string-name>. <article-title>Chlorogenic acid functions as a novel agonist of PPARgamma2 during the differentiation of mouse 3T3‐L1 preadipocytes</article-title>. <source xml:lang="en"/>Biomed Res Int. <year>2018</year>;<volume>2018</volume>:<fpage>8594767</fpage>.<pub-id pub-id-type="pmid">30627576</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0193">
<label>193</label>
<mixed-citation id="jcmm15028-cit-0193" publication-type="journal">
<string-name>
<surname>Matsubara</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Takakura</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Urata</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Geranylgeraniol induces PPARgamma expression and enhances the biological effects of a PPARgamma agonist in adipocyte lineage cells</article-title>. <source xml:lang="en"/>In Vivo. <year>2018</year>;<volume>32</volume>:<fpage>1339</fpage>‐<lpage>1344</lpage>.<pub-id pub-id-type="pmid">30348686</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0194">
<label>194</label>
<mixed-citation id="jcmm15028-cit-0194" publication-type="journal">
<string-name>
<surname>Lu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yao</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Gong</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>Gentiopicroside ameliorates diabetic peripheral neuropathy by modulating PPAR‐ Gamma/AMPK/ACC signaling pathway</article-title>. <source xml:lang="en"/>Cell Physiol Biochem. <year>2018</year>;<volume>50</volume>:<fpage>585</fpage>‐<lpage>596</lpage>.<pub-id pub-id-type="pmid">30308492</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0195">
<label>195</label>
<mixed-citation id="jcmm15028-cit-0195" publication-type="journal">
<string-name>
<surname>Balakrishnan</surname>
<given-names>BB</given-names>
</string-name>, <string-name>
<surname>Krishnasamy</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Choi</surname>
<given-names>KC</given-names>
</string-name>. <article-title>Moringa concanensis Nimmo ameliorates hyperglycemia in 3T3‐L1 adipocytes by upregulating PPAR‐gamma, C/EBP‐alpha via Akt signaling pathway and STZ‐induced diabetic rats</article-title>. <source xml:lang="en"/>Biomed Pharmacother. <year>2018</year>;<volume>103</volume>:<fpage>719</fpage>‐<lpage>728</lpage>.<pub-id pub-id-type="pmid">29680740</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0196">
<label>196</label>
<mixed-citation id="jcmm15028-cit-0196" publication-type="journal">
<string-name>
<surname>Ochiai</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Takeuchi</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Nozaki</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Ishihara</surname>
<given-names>KO</given-names>
</string-name>, <string-name>
<surname>Matsuo</surname>
<given-names>T</given-names>
</string-name>. <article-title>Kaempferia parviflora ethanol extract, a peroxisome proliferator‐activated receptor gamma ligand‐binding agonist, improves glucose tolerance and suppresses fat accumulation in diabetic NSY mice</article-title>. <source xml:lang="en"/>J Food Sci. <year>2019</year>;<volume>84</volume>:<fpage>339</fpage>‐<lpage>348</lpage>.<pub-id pub-id-type="pmid">30726580</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0197">
<label>197</label>
<mixed-citation id="jcmm15028-cit-0197" publication-type="journal">
<string-name>
<surname>Balakrishnan</surname>
<given-names>BB</given-names>
</string-name>, <string-name>
<surname>Krishnasamy</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Mayakrishnan</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Selvaraj</surname>
<given-names>A</given-names>
</string-name>. <article-title>Moringa concanensis Nimmo extracts ameliorates hyperglycemia‐mediated oxidative stress and upregulates PPARgamma and GLUT4 gene expression in liver and pancreas of streptozotocin‐nicotinamide induced diabetic rats</article-title>. <source xml:lang="en"/>Biomed Pharmacother. <year>2019</year>;<volume>112</volume>:<fpage>108688</fpage>.<pub-id pub-id-type="pmid">30798121</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0198">
<label>198</label>
<mixed-citation id="jcmm15028-cit-0198" publication-type="journal">
<string-name>
<surname>Zou</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Gao</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Deoxyelephantopin inhibits cancer cell proliferation and functions as a selective partial agonist against PPARgamma</article-title>. <source xml:lang="en"/>Biochem Pharmacol. <year>2008</year>;<volume>75</volume>:<fpage>1381</fpage>‐<lpage>1392</lpage>.<pub-id pub-id-type="pmid">18164690</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0199">
<label>199</label>
<mixed-citation id="jcmm15028-cit-0199" publication-type="journal">
<string-name>
<surname>Lu</surname>
<given-names>ZH</given-names>
</string-name>, <string-name>
<surname>Peng</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>RX</given-names>
</string-name>, et al. <article-title>Dihydroartemisinin inhibits colon cancer cell viability by inducing apoptosis through up‐regulation of PPARgamma expression</article-title>. <source xml:lang="en"/>Saudi J Biol Sci. <year>2018</year>;<volume>25</volume>:<fpage>372</fpage>‐<lpage>376</lpage>.<pub-id pub-id-type="pmid">29472793</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0200">
<label>200</label>
<mixed-citation id="jcmm15028-cit-0200" publication-type="journal">
<string-name>
<surname>Au‐Yeung</surname>
<given-names>KK</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>PL</given-names>
</string-name>, <string-name>
<surname>Chan</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>WY</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>SS</given-names>
</string-name>, <string-name>
<surname>Ko</surname>
<given-names>JK</given-names>
</string-name>. <article-title>Herbal isoprenols induce apoptosis in human colon cancer cells through transcriptional activation of PPARgamma</article-title>. <source xml:lang="en"/>Cancer Invest. <year>2008</year>;<volume>26</volume>:<fpage>708</fpage>‐<lpage>717</lpage>.<pub-id pub-id-type="pmid">18608213</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0201">
<label>201</label>
<mixed-citation id="jcmm15028-cit-0201" publication-type="journal">
<string-name>
<surname>Liu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Si</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Ma</surname>
<given-names>Y</given-names>
</string-name>, et al. <article-title>Hydroxysafflor‐yellow A induces human gastric carcinoma BGC‐823 cell apoptosis by activating peroxisome proliferator‐activated receptor gamma (PPARgamma)</article-title>. <source xml:lang="en"/>Med Sci Monit. <year>2018</year>;<volume>24</volume>:<fpage>803</fpage>‐<lpage>811</lpage>.<pub-id pub-id-type="pmid">29417935</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0202">
<label>202</label>
<mixed-citation id="jcmm15028-cit-0202" publication-type="journal">
<string-name>
<surname>Qu</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Qu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Guo</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>BT</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>HH</given-names>
</string-name>. <article-title>Luteolin potentiates the sensitivity of colorectal cancer cell lines to oxaliplatin through the PPARgamma/OCTN2 pathway</article-title>. <source xml:lang="en"/>Anticancer Drugs. <year>2014</year>;<volume>25</volume>:<fpage>1016</fpage>‐<lpage>1027</lpage>.<pub-id pub-id-type="pmid">25075794</pub-id></mixed-citation>
</ref>
<ref id="jcmm15028-bib-0203">
<label>203</label>
<mixed-citation id="jcmm15028-cit-0203" publication-type="journal">
<string-name>
<surname>Yang</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>YL</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>HY</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>ML</given-names>
</string-name>. <article-title>Lycopene and the LXRalpha agonist T0901317 synergistically inhibit the proliferation of androgen‐independent prostate cancer cells via the PPARgamma‐LXRalpha‐ABCA1 pathway</article-title>. <source xml:lang="en"/>J Nutr Biochem. <year>2012</year>;<volume>23</volume>:<fpage>1155</fpage>‐<lpage>1162</lpage>.<pub-id pub-id-type="pmid">22137263</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>